false--12-31Q12020000167433514108200024530001435350001310240004553000135577000P1Y14182000024530001442730001403300010630001297000070000000.010.01900000000900000000124000001939411006680031004874853428311000534200034229690000.02550.06000.03940.04880.02250.01900.01300.0463P30Y1.360.021.381.330.031.3691853600051980009237340001.360.021.381.330.031.3610058000210000079580001419070002453000144360000167042000561600017265800077100010600000011200000.010.01900000009000000000004346847000144000434670300073416600041800073374800010636065701063606571045305720104530572 0001674335 2020-01-01 2020-03-28 0001674335 2019-01-01 2019-03-30 0001674335 2020-05-04 0001674335 2019-12-31 0001674335 2020-03-28 0001674335 us-gaap:AdditionalPaidInCapitalMember 2019-03-30 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2018-12-31 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2019-01-01 2019-03-30 0001674335 us-gaap:RetainedEarningsMember 2020-03-28 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-01-01 2020-03-28 0001674335 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-30 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-12-31 0001674335 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-28 0001674335 us-gaap:RetainedEarningsMember 2019-12-31 0001674335 us-gaap:RetainedEarningsMember 2018-12-31 0001674335 us-gaap:CommonStockMember 2019-01-01 2019-03-30 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2019-03-30 0001674335 us-gaap:OtherAdditionalCapitalMember 2019-03-30 0001674335 us-gaap:OtherAdditionalCapitalMember 2020-03-28 0001674335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-28 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-01-01 2019-03-30 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2020-03-28 0001674335 us-gaap:OtherAdditionalCapitalMember 2020-01-01 2020-03-28 0001674335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-30 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2018-12-31 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-03-28 0001674335 us-gaap:AdditionalPaidInCapitalMember 2020-03-28 0001674335 us-gaap:OtherAdditionalCapitalMember 2019-01-01 2019-03-30 0001674335 us-gaap:OtherAdditionalCapitalMember 2019-12-31 0001674335 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001674335 us-gaap:PreferredStockMember 2019-12-31 0001674335 2019-03-30 0001674335 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2019-03-30 0001674335 jeld:AccountingStandardsUpdate201613Member us-gaap:RetainedEarningsMember 2020-01-01 0001674335 us-gaap:PreferredStockMember 2018-12-31 0001674335 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001674335 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-28 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2020-01-01 2020-03-28 0001674335 us-gaap:RetainedEarningsMember 2019-03-30 0001674335 us-gaap:AccountingStandardsUpdate201602Member us-gaap:RetainedEarningsMember 2019-01-01 0001674335 jeld:EmployeeStockNotesMember us-gaap:OtherAdditionalCapitalMember 2019-12-31 0001674335 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OtherAdditionalCapitalMember 2018-12-31 0001674335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:CommonStockMember 2020-01-01 2020-03-28 0001674335 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-28 0001674335 2018-12-31 0001674335 jeld:AccountingStandardsUpdate201613Member 2020-01-01 0001674335 jeld:VPIQualityWindowsInc.Member 2020-01-01 2020-03-28 0001674335 jeld:VPIQualityWindowsInc.Member 2020-03-28 0001674335 jeld:VPIQualityWindowsInc.Member 2019-03-31 2020-03-28 0001674335 jeld:VPIQualityWindowsInc.Member 2019-03-30 0001674335 jeld:VPIQualityWindowsInc.Member 2019-03-01 2019-03-30 0001674335 us-gaap:PropertyPlantAndEquipmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:PropertyPlantAndEquipmentMember 2020-01-01 2020-03-28 0001674335 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-28 0001674335 us-gaap:CostOfSalesMember 2019-01-01 2019-03-30 0001674335 us-gaap:CostOfSalesMember 2020-01-01 2020-03-28 0001674335 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-30 0001674335 jeld:EuropeSegmentMember 2020-03-28 0001674335 jeld:AustralasiaSegmentMember 2019-12-31 0001674335 jeld:EuropeSegmentMember 2019-12-31 0001674335 jeld:AustralasiaSegmentMember 2020-03-28 0001674335 jeld:NorthAmericaSegmentMember 2020-03-28 0001674335 jeld:AustralasiaSegmentMember 2020-01-01 2020-03-28 0001674335 jeld:NorthAmericaSegmentMember 2020-01-01 2020-03-28 0001674335 jeld:NorthAmericaSegmentMember 2019-12-31 0001674335 jeld:EuropeSegmentMember 2020-01-01 2020-03-28 0001674335 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-01-01 2020-03-28 0001674335 us-gaap:CustomerRelationshipsMember 2019-12-31 0001674335 us-gaap:TrademarksAndTradeNamesMember 2019-12-31 0001674335 us-gaap:IntellectualPropertyMember 2019-12-31 0001674335 us-gaap:ComputerSoftwareIntangibleAssetMember 2019-12-31 0001674335 us-gaap:IntellectualPropertyMember 2020-03-28 0001674335 us-gaap:CustomerRelationshipsMember 2020-03-28 0001674335 us-gaap:TrademarksAndTradeNamesMember 2020-03-28 0001674335 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-03-28 0001674335 srt:MinimumMember 2020-01-01 2020-03-28 0001674335 srt:MaximumMember jeld:NorthAmericaSegmentMember 2020-03-28 0001674335 srt:MaximumMember 2020-01-01 2020-03-28 0001674335 srt:MinimumMember jeld:NorthAmericaSegmentMember 2020-03-28 0001674335 us-gaap:ConvertibleNotesPayableMember 2020-03-28 0001674335 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-12-31 0001674335 jeld:InstallmentLoanMember us-gaap:NotesPayableToBanksMember 2020-03-28 0001674335 us-gaap:SecuredDebtMember 2020-03-28 0001674335 us-gaap:SecuredDebtMember 2019-12-31 0001674335 us-gaap:SeniorNotesMember 2020-03-28 0001674335 us-gaap:ConvertibleNotesPayableMember 2019-12-31 0001674335 us-gaap:SeniorNotesMember 2019-12-31 0001674335 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-03-28 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2020-03-28 0001674335 jeld:InstallmentLoanMember us-gaap:NotesPayableToBanksMember 2019-12-31 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2019-12-31 0001674335 us-gaap:SecuredDebtMember jeld:AustralianFacilityMember us-gaap:NotesPayableToBanksMember 2019-06-01 2019-06-29 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2019-09-28 0001674335 jeld:SeniorNoteMaturingDecember2027Member us-gaap:SeniorNotesMember 2017-12-31 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember jeld:BBSYMember 2019-05-31 2019-05-31 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2019-02-28 0001674335 us-gaap:SeniorNotesMember 2017-12-31 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-30 0001674335 us-gaap:SecuredDebtMember jeld:AustralianFacilityMember 2019-06-29 0001674335 us-gaap:RevolvingCreditFacilityMember jeld:ABLFacilityMember us-gaap:LineOfCreditMember 2020-01-01 2020-03-28 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2020-03-28 0001674335 srt:MaximumMember us-gaap:SecuredDebtMember jeld:AustralianFacilityMember us-gaap:NotesPayableToBanksMember jeld:BBSYMember 2019-06-01 2019-06-29 0001674335 srt:MinimumMember us-gaap:SecuredDebtMember jeld:AustralianFacilityMember us-gaap:NotesPayableToBanksMember jeld:BBSYMember 2019-06-01 2019-06-29 0001674335 us-gaap:RevolvingCreditFacilityMember 2020-03-28 0001674335 us-gaap:RevolvingCreditFacilityMember jeld:ABLFacilityMember us-gaap:LineOfCreditMember 2020-03-28 0001674335 us-gaap:SecuredDebtMember jeld:AustralianFacilityMember us-gaap:NotesPayableToBanksMember 2020-03-28 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember jeld:BBSYMember 2019-06-01 2019-06-29 0001674335 jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2019-09-01 2019-09-28 0001674335 jeld:SeniorNoteMaturingDecember2025Member us-gaap:SeniorNotesMember 2017-12-31 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2019-05-31 2019-05-31 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2019-06-01 2019-06-29 0001674335 us-gaap:SecuredDebtMember 2007-12-01 2007-12-31 0001674335 srt:MinimumMember jeld:InstallmentLoanMember us-gaap:NotesPayableToBanksMember 2020-03-28 0001674335 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-03-28 0001674335 srt:MaximumMember jeld:InstallmentLoanMember us-gaap:NotesPayableToBanksMember 2020-03-28 0001674335 srt:MaximumMember us-gaap:SeniorNotesMember 2020-03-28 0001674335 srt:MaximumMember jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2020-03-28 0001674335 srt:MinimumMember jeld:TermLoanMember us-gaap:NotesPayableToBanksMember 2020-03-28 0001674335 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-03-28 0001674335 srt:MinimumMember us-gaap:SeniorNotesMember 2020-03-28 0001674335 us-gaap:OperatingSegmentsMember 2020-01-01 2020-03-28 0001674335 us-gaap:OperatingSegmentsMember jeld:AustralasiaSegmentMember 2020-01-01 2020-03-28 0001674335 us-gaap:OperatingSegmentsMember jeld:EuropeSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember 2019-01-01 2019-03-30 0001674335 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember jeld:AustralasiaSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:IntersegmentEliminationMember jeld:AustralasiaSegmentMember 2020-01-01 2020-03-28 0001674335 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-28 0001674335 us-gaap:IntersegmentEliminationMember jeld:EuropeSegmentMember 2020-01-01 2020-03-28 0001674335 us-gaap:OperatingSegmentsMember jeld:NorthAmericaSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember jeld:EuropeSegmentMember 2020-01-01 2020-03-28 0001674335 jeld:NorthAmericaSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember jeld:NorthAmericaSegmentMember 2020-01-01 2020-03-28 0001674335 jeld:AustralasiaSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:IntersegmentEliminationMember jeld:NorthAmericaSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-28 0001674335 us-gaap:IntersegmentEliminationMember jeld:EuropeSegmentMember 2019-01-01 2019-03-30 0001674335 jeld:EuropeSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:IntersegmentEliminationMember jeld:NorthAmericaSegmentMember 2020-01-01 2020-03-28 0001674335 us-gaap:IntersegmentEliminationMember jeld:AustralasiaSegmentMember 2019-01-01 2019-03-30 0001674335 2019-11-04 0001674335 2018-04-30 0001674335 us-gaap:EmployeeStockOptionMember us-gaap:CommonStockMember 2019-01-01 2019-03-30 0001674335 us-gaap:EmployeeStockOptionMember us-gaap:CommonStockMember 2020-01-01 2020-03-28 0001674335 us-gaap:PerformanceSharesMember 2019-01-01 2019-03-30 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-30 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-28 0001674335 us-gaap:PerformanceSharesMember 2020-01-01 2020-03-28 0001674335 us-gaap:PerformanceSharesMember 2019-01-01 2019-03-30 0001674335 us-gaap:PerformanceSharesMember 2020-01-01 2020-03-28 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-28 0001674335 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-30 0001674335 us-gaap:EmployeeSeveranceMember 2020-01-01 2020-03-28 0001674335 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-03-30 0001674335 us-gaap:OtherRestructuringMember 2020-01-01 2020-03-28 0001674335 us-gaap:EmployeeSeveranceMember 2019-03-30 0001674335 us-gaap:OtherRestructuringMember 2019-01-01 2019-03-30 0001674335 us-gaap:OtherRestructuringMember 2019-03-30 0001674335 us-gaap:OtherRestructuringMember 2019-12-31 0001674335 us-gaap:EmployeeSeveranceMember 2020-03-28 0001674335 us-gaap:OtherRestructuringMember 2018-12-31 0001674335 us-gaap:EmployeeSeveranceMember 2019-12-31 0001674335 us-gaap:OtherRestructuringMember 2020-03-28 0001674335 us-gaap:EmployeeSeveranceMember 2018-12-31 0001674335 jeld:InterestRateSwapsEffectivePeriodFourMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0001674335 jeld:InterestRateSwapsEffectivePeriodFourMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-01 2017-12-31 0001674335 jeld:ForeignExchangeContractsConsolidatedEarningsMember us-gaap:NondesignatedMember 2020-03-28 0001674335 us-gaap:InterestRateCapMember 2019-03-30 0001674335 jeld:ForeignExchangeContractsForecastedTransactionsMember us-gaap:NondesignatedMember 2020-03-28 0001674335 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-01-01 2019-03-30 0001674335 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-30 0001674335 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-01-01 2020-03-28 0001674335 jeld:ForeignCurrencyExchangeContractsIntercompanyLoansandInterestMember us-gaap:NondesignatedMember 2020-03-28 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-03-28 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-12-31 0001674335 us-gaap:OtherAssetsMember us-gaap:InterestRateCapMember us-gaap:NondesignatedMember 2019-12-31 0001674335 us-gaap:OtherAssetsMember us-gaap:InterestRateCapMember us-gaap:NondesignatedMember 2020-03-28 0001674335 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-03-28 0001674335 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001674335 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-28 0001674335 us-gaap:ChangeDuringPeriodFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-28 0001674335 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-28 0001674335 us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-28 0001674335 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-28 0001674335 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2020-03-28 0001674335 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:OtherCurrentAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001674335 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001674335 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001674335 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001674335 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001674335 us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001674335 us-gaap:ChangeDuringPeriodFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001674335 jeld:SteveandSonsMember jeld:LegalCostMember 2019-04-12 2019-04-12 0001674335 jeld:SettlementOneMember jeld:SteveandSonsMember 2018-02-01 2018-02-28 0001674335 jeld:SteveandSonsMember 2019-03-13 2019-03-13 0001674335 srt:MinimumMember jeld:DomesticProductLiabilityMember 2020-01-01 2020-03-28 0001674335 jeld:SteveandSonsMember 2019-12-31 0001674335 jeld:SettlementTwoMember jeld:SteveandSonsMember 2018-02-01 2018-02-28 0001674335 srt:MinimumMember jeld:AutoGeneralLiabilityPersonalInjuryandWorkersCompensationMember 2020-01-01 2020-03-28 0001674335 jeld:SteveandSonsMember 2018-05-11 2018-05-11 0001674335 jeld:SettlementOneMember jeld:SteveandSonsMember 2019-03-13 2019-03-13 0001674335 jeld:SteveandSonsMember 2019-11-19 2019-11-19 0001674335 jeld:SteveandSonsMember jeld:AttorneyFeesMember 2019-04-12 2019-04-12 0001674335 jeld:SettlementTwoMember jeld:SteveandSonsMember 2019-03-13 2019-03-13 0001674335 srt:MaximumMember jeld:AutoGeneralLiabilityPersonalInjuryandWorkersCompensationMember 2020-01-01 2020-03-28 0001674335 srt:MaximumMember jeld:DomesticProductLiabilityMember 2020-01-01 2020-03-28 0001674335 jeld:PennsylvaniaDepartmentofEnvironmentalProtectionMember 2020-03-28 0001674335 jeld:VPIQualityWindowsInc.Member jeld:AcquiredLeaseMember srt:AffiliatedEntityMember 2020-03-28 0001674335 srt:AffiliatedEntityMember 2019-05-31 0001674335 jeld:VPIQualityWindowsInc.Member jeld:AcquiredLeaseMember srt:AffiliatedEntityMember 2019-03-30 0001674335 jeld:VPIQualityWindowsInc.Member jeld:AcquiredLeaseMember srt:AffiliatedEntityMember 2019-08-01 2019-08-31 0001674335 srt:AffiliatedEntityMember 2020-03-28 0001674335 jeld:SalesOfSubsidiaryMember srt:AffiliatedEntityMember jeld:BoardOfDirectorsMemberMember 2020-01-01 2020-03-28 0001674335 jeld:SalesOfSubsidiaryMember srt:AffiliatedEntityMember jeld:BoardOfDirectorsMemberMember 2019-05-01 2019-05-31 0001674335 srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-03-30 0001674335 srt:RestatementAdjustmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember jeld:NorthAmericaSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember srt:RestatementAdjustmentMember jeld:NorthAmericaSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember srt:RestatementAdjustmentMember jeld:AustralasiaSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember srt:RestatementAdjustmentMember jeld:EuropeSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember srt:RestatementAdjustmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:CorporateNonSegmentMember srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-03-30 0001674335 us-gaap:CorporateNonSegmentMember srt:RestatementAdjustmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember jeld:AustralasiaSegmentMember 2019-01-01 2019-03-30 0001674335 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember jeld:EuropeSegmentMember 2019-01-01 2019-03-30 0001674335 2018-01-01 2018-12-31 0001674335 srt:RestatementAdjustmentMember 2018-01-01 2018-12-31 0001674335 srt:ScenarioPreviouslyReportedMember 2018-01-01 2018-12-31 0001674335 jeld:SeniorSecuredNotesMaturingMay2025Member us-gaap:SubsequentEventMember 2020-05-04 0001674335 us-gaap:SecuredDebtMember jeld:AmendedFloatingRateRevolvingLoanFacilityMember us-gaap:NotesPayableToBanksMember us-gaap:SubsequentEventMember 2020-05-01 2020-05-01 0001674335 jeld:InterchangeableFacilityMember jeld:AustraliaSeniorSecuredCreditFacilityMember us-gaap:LineOfCreditMember 2020-01-01 2020-03-28 0001674335 us-gaap:SecuredDebtMember jeld:AmendedFloatingRateRevolvingLoanFacilityMember us-gaap:NotesPayableToBanksMember us-gaap:SubsequentEventMember jeld:BBSYMember 2020-05-01 2020-05-01 xbrli:pure jeld:tranch jeld:segment iso4217:AUD iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:DKK jeld:instrument jeld:lease
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 10-Q
____________________________

☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 28, 2020
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____
Commission File Number: 001-38000
____________________________
JELD-WEN Holding, Inc.
(Exact name of registrant as specified in its charter)
____________________________
Delaware
 
93-1273278
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
2645 Silver Crescent Drive
Charlotte, North Carolina 28273
(Address of principal executive offices, zip code)
(704) 378-5700
(Registrant’s telephone number, including area code)
____________________________

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock (par value $0.01 per share)
 
JELD
 
New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
☒
 
Accelerated filer
 
☐
 
 
 
 
Non-accelerated filer
 
o
 
Smaller reporting company
 
☐
 
 
 
 
 
 
 
 
 
 
 
Emerging growth company
 
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The registrant had 100,474,713 shares of Common Stock, par value $0.01 per share, outstanding as of May 4, 2020.




JELD-WEN HOLDING, Inc.
- Table of Contents –
 
 
Page No.
Part I - Financial Information
 
 
 
 
Item 1.
Unaudited Financial Statements
 
 
Consolidated Statements of Operations
5
 
Consolidated Statements of Comprehensive Income (Loss)
6
 
Consolidated Balance Sheets
7
 
Consolidated Statements of Equity
8
 
Consolidated Statements of Cash Flows
9
 
Notes to Unaudited Consolidated Financial Statements
10
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
31
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
39
Item 4.
Controls and Procedures
39
 
 
 
Part II - Other Information
 
 
 
 
Item 1.
Legal Proceedings
40
Item 1A.
Risk Factors
42
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
44
Item 5.
Other Information
44
Item 6.
Exhibits
45
 
 
 
 
Signature
46



2


Glossary of Terms

When the following terms and abbreviations appear in the text of this report, they have the meanings indicated below:
ABL Facility
Our $400 million asset-based loan revolving credit facility, dated as of October 15, 2014 and as amended from time to time, with JWI (as hereinafter defined) and JELD-WEN of Canada, Ltd., as borrowers, the guarantors party thereto, a syndicate of lenders, and Wells Fargo Bank, N.A., as administrative agent
ABS
American Building Supply, Inc.
Adjusted EBITDA
A supplemental non-GAAP financial measure of operating performance not based on any standardized methodology prescribed by GAAP that we define as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity earnings of non-consolidated entities; income tax (benefit) expense; depreciation and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation expense; non-cash foreign exchange transaction/translation (income) loss; other non-cash items; other items; and costs related to debt restructuring and debt refinancing
ASC
Accounting Standards Codification
ASU
Accounting Standards Update
AUD
Australian Dollar
Australia Senior Secured Credit Facility
Our senior secured credit facility, dated as of October 6, 2015 and as amended from time to time, with certain of our Australian subsidiaries, as borrowers, and Australia and New Zealand Banking Group Limited, as lender
BBSY
Bank Bill Swap Bid Rate
Bylaws
Amended and Restated Bylaws of JELD-WEN Holding, Inc.
CAP
Cleanup Action Plan
Charter
Restated Certificate of Incorporation of JELD-WEN Holding, Inc.
Class B-1 Common Stock
Shares of our Class B-1 common stock, par value $0.01 per share, all of which were converted into shares of our Common Stock on February 1, 2017
CMI
CraftMaster Manufacturing, Inc.
COA
Consent Order and Agreement
CODM
Chief Operating Decision Maker
Common Stock
The 900,000,000 shares of common stock, par value $0.01 per share, authorized under our Charter
Corporate Credit Facilities
Collectively, our ABL Facility and our Term Loan Facility
COVID-19
A novel strain of the 2019-nCov coronavirus
Credit Facilities
Collectively, our Corporate Credit Facilities and our Australia Senior Secured Credit Facility as well as other acquired term loans and revolving credit facilities
DKK
Danish Krone
ERP
Enterprise Resource Planning
ESOP
JELD-WEN, Inc. Employee Stock Ownership and Retirement Plan
Exchange Act
Securities Exchange Act of 1934, as amended
FASB
Financial Accounting Standards Board
10-K
Annual Report on Form 10-K for the fiscal year ended December 31, 2019
GAAP
Generally Accepted Accounting Principles in the United States
GHGs
Greenhouse Gases
GILTI
Global Intangible Low-Taxed Income
JELD-WEN
JELD-WEN Holding, Inc., together with its consolidated subsidiaries where the context requires
JEM
JELD-WEN Excellence Model
JWH
JELD-WEN Holding, Inc., a Delaware corporation
JWI
JELD-WEN, Inc., a Delaware corporation
LIBOR
London Interbank Offered Rate
MD&A
Management’s Discussion and Analysis of Financial Condition and Results of Operations

3


Onex
Onex Partners III LP and certain affiliates
PaDEP
Pennsylvania Department of Environmental Protection
Preferred Stock
90,000,000 shares of Preferred Stock, par value $0.01 per share, authorized under our Charter
PSU
Performance stock unit
R&R
Repair and remodel
RSU
Restricted stock unit
SEC
Securities and Exchange Commission
Securities Act
Securities Act of 1933, as amended
Senior Notes
$800.0 million of unsecured notes issued in December 2017 in a private placement in two tranches: $400.0 million bearing interest at 4.625% and maturing in December 2025 and $400.0 million bearing interest at 4.875% and maturing in December 2027
Series A Convertible Preferred Stock
Our Series A-1 Convertible Preferred Stock, par value $0.01 per share, Series A-2 Convertible Preferred Stock, par value $0.01 per share, Series A-3 Convertible Preferred Stock, par value $0.01 per share, and Series A-4 Convertible Preferred Stock, par value $0.01 per share, all of which were converted into shares of our common stock on February 1, 2017
SG&A
Selling, general, and administrative expenses
Tax Act
Tax Cuts and Jobs Act
Term Loan Facility
Our term loan facility, dated as of October 15, 2014, and as amended from time to time with JWI, as borrower, the guarantors party thereto, a syndicate of lenders, and Bank of America, N.A., as administrative agent
U.S.
United States of America
VPI
VPI Quality Windows, Inc.
WADOE
Washington State Department of Ecology
CERTAIN TRADEMARKS, TRADE NAMES AND SERVICE MARKS
This 10-Q includes trademarks, trade names, and service marks owned by us. Our U.S. window and door trademarks include JELD-WEN®, AuraLast®, MiraTEC®, Extira®, LaCANTINATM, MMI DoorTM, KaronaTM, ImpactGard®, JW®, Aurora®, IWP®, True BLUTM, ABSTM, and VPITM . Our trademarks are either registered or have been used as common law trademarks by us. The trademarks we use outside the U.S. include the Stegbar®, Regency®, William Russell Doors®, Airlite®, Trend®, The Perfect FitTM, Aneeta®, Breezway®, KolderTM , Corinthian® and A&LTM marks in Australia, and Swedoor®, Dooria®, DANA®, MattioviTM, Alupan® and Domoferm® marks in Europe. ENERGY STAR® is a registered trademark of the U.S. Environmental Protection Agency. This 10-Q contains additional trademarks, trade names, and service marks of others, which are, to our knowledge, the property of their respective owners. Solely for convenience, trademarks, trade names, and service marks referred to in this 10-Q appear without the ®, ™ or SM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks, trade names, and service marks. We do not intend our use of other parties’ trademarks, trade names, or service marks to imply, and such use or display should not be construed to imply, a relationship with, or endorsement or sponsorship of us by, these other parties.

4


PART I - FINANCIAL INFORMATION
Item 1 - Unaudited Financial Statements

JELD-WEN HOLDING, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
 
Three Months Ended
(amounts in thousands, except share and per share data)
March 28, 2020
 
March 30, 2019
Net revenues
$
979,187

 
$
1,010,260

Cost of sales
784,818

 
802,131

Gross margin
194,369

 
208,129

Selling, general and administrative
172,584

 
164,100

Impairment and restructuring charges
6,545

 
3,719

Operating income
15,240

 
40,310

Interest expense, net
16,604

 
17,656

Other income
(2,331
)
 
(3,472
)
Income before taxes
967

 
26,126

Income tax expense
1,197

 
10,349

Net income (loss)
$
(230
)
 
$
15,777

 
 
 
 
Weighted average common shares outstanding:
 
 
 
Basic
100,646,850

 
100,643,509

Diluted
100,646,850

 
101,461,293

Net income (loss) per share
 
 
 
Basic
$
—

 
$
0.16

Diluted
$
—

 
$
0.16



























The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

5


JELD-WEN HOLDING, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(unaudited)
 
Three Months Ended
(amounts in thousands)
March 28, 2020
 
March 30, 2019
Net income (loss)
$
(230
)
 
$
15,777

Other comprehensive income (loss), net of tax:
 
 
 
Foreign currency translation adjustments, net tax of $0
(53,639
)
 
(12,046
)
Interest rate hedge adjustments, net of tax (benefit) expense of $0 and ($112), respectively
—

 
550

Defined benefit pension plans, net of tax expense of $1,060 and $771, respectively
2,763

 
1,454

 
(50,876
)
 
(10,042
)
Comprehensive income (loss)
$
(51,106
)
 
$
5,735











































The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

6

JELD-WEN HOLDING, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited)
(amounts in thousands, except share and per share data)
March 28,
2020
 
December 31,
2019
ASSETS
 
 
 
Current assets
 
 
 
Cash and cash equivalents
$
214,297

 
$
225,962

Restricted cash
312

 
3,914

Accounts receivable, net
539,252

 
469,762

Inventories
524,022

 
505,078

Other current assets
59,436

 
38,562

Total current assets
1,337,319

 
1,243,278

Property and equipment, net
829,730

 
864,375

Deferred tax assets
181,642

 
183,837

Goodwill
587,043

 
602,500

Intangible assets, net
237,233

 
250,327

Operating lease assets, net
200,472

 
202,053

Other assets
33,139

 
34,962

Total assets
$
3,406,578

 
$
3,381,332

LIABILITIES AND EQUITY
 
 
 
Current liabilities
 
 
 
Accounts payable
$
281,863

 
$
294,951

Accrued payroll and benefits
124,600

 
109,386

Accrued expenses and other current liabilities
287,321

 
298,603

Current maturities of long-term debt
64,740

 
65,846

Total current liabilities
758,524

 
768,786

Long-term debt
1,547,115

 
1,451,526

Unfunded pension liability
105,281

 
107,937

Operating lease liability
164,296

 
164,026

Deferred credits and other liabilities
68,731

 
67,682

Deferred tax liabilities
8,863

 
9,288

Total liabilities
2,652,810

 
2,569,245

Commitments and contingencies (Note 21)

 

Shareholders’ equity
 
 
 
Preferred Stock, par value $0.01 per share, 90,000,000 shares authorized; no shares issued and outstanding
—

 
—

Common Stock: 900,000,000 shares authorized, par value $0.01 per share, 100,487,485 shares outstanding as of March 28, 2020; 900,000,000 shares authorized, par value $0.01 per share, 100,668,003 shares outstanding as of December 31, 2019
1,005

 
1,007

Additional paid-in capital
675,268

 
671,772

Retained earnings
279,646

 
290,583

Accumulated other comprehensive loss
(202,151
)
 
(151,275
)
Total shareholders’ equity
753,768

 
812,087

Total liabilities and shareholders’ equity
$
3,406,578

 
$
3,381,332





The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

7

JELD-WEN HOLDING, INC.
CONSOLIDATED STATEMENTS OF EQUITY
 
March 28, 2020
 
March 30, 2019
(amounts in thousands, except share and per share amounts)
Shares
 
Amount
 
Shares
 
Amount
Preferred stock, $0.01 par value per share
—

 
$
—

 
—

 
$
—

Common stock, $0.01 par value per share
 
 
 
 
 
 
 
Balance at beginning of period
100,668,003
 
$
1,007

 
101,310,862
 
$
1,013

Shares issued for exercise/vesting of share-based compensation awards
94,471
 
1

 
303,093
 
3

Shares repurchased
(265,589)
 
(3
)
 
(939,798)
 
(9
)
Shares surrendered for tax obligations for employee share-based transactions
(9,400)
 
—

 
(9,335)
 
—

Balance at period end
100,487,485
 
$
1,005

 
100,664,822
 
$
1,007

Additional paid-in capital
 
 
 
 
 
 
 
Balance at beginning of period
 
$
672,445

 
 
 
$
659,241

Shares issued for exercise/vesting of share-based compensation awards
 
—

 
 
 
1,287

Shares surrendered for tax obligations for employee share-based transactions
 
(237
)
 
 
 
(164
)
Amortization of share-based compensation
 
3,733

 
 
 
2,473

Balance at period end
 
675,941

 
 
 
662,837

Employee stock notes
 
 
 
 
 
 
 
Balance at beginning of period
 
(673
)
 
 
 
(648
)
Net issuances, payments and accrued interest on notes
 
—

 
 
 
(6
)
Balance at period end
 
(673
)
 
 
 
(654
)
Balance at period end
 
$
675,268

 
 
 
$
662,183

Retained earnings
 
 
 
 
 
 
 
Balance at beginning of period
 
$
290,583

 
 
 
$
246,833

Share repurchased
 
(4,997
)
 
 
 
(14,990
)
Adoption of new accounting standard ASU No. 2016-02
 
—

 
 
 
761

Adoption of new accounting standard ASU No. 2016-13
 
$
(5,710
)
 
 
 
—

Net (loss) income
 
(230
)
 
 
 
15,777

Balance at period end
 
$
279,646

 
 
 
$
248,381

Accumulated other comprehensive income (loss)
 
 
 
 
 
 
 
Balance at beginning of period
 
$
(151,275
)
 
 
 
$
(144,805
)
Foreign currency adjustments
 
(53,639
)
 
 
 
(12,046
)
Unrealized gain on interest rate hedges
 
—

 
 
 
550

Net actuarial pension gain
 
2,763

 
 
 
1,454

Balance at period end
 
$
(202,151
)
 
 
 
$
(154,847
)
 
 
 
 
 
 
 
 
Total shareholders’ equity at period end
 
$
753,768

 
 
 
$
756,724















The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

8

JELD-WEN HOLDING, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
 
 
Three Months Ended
(amounts in thousands)
 
March 28,
2020
 
March 30,
2019
OPERATING ACTIVITIES
 
 
 
 
Net income (loss)
 
$
(230
)
 
$
15,777

Adjustments to reconcile net income (loss) to cash used in operating activities:
 
 
 
 
Depreciation and amortization
 
33,446

 
30,898

Deferred income taxes
 
604

 
(2,377
)
(Gain) loss on sale of business units, property and equipment
 
(2,073
)
 
614

Adjustment to carrying value of assets
 
4,254

 
1,634

Amortization of deferred financing costs
 
492

 
490

Stock-based compensation
 
3,733

 
2,596

Contributions to U.S. pension plan
 
(1,619
)
 
(1,375
)
Amortization of U.S. pension expense
 
2,225

 
2,225

Other items, net
 
13,382

 
(8,212
)
Net change in operating assets and liabilities, net of effect of acquisitions:
 
 
 
 
Accounts receivable
 
(95,477
)
 
(89,359
)
Inventories
 
(32,686
)
 
(33,745
)
Other assets
 
(17,840
)
 
(7,502
)
Accounts payable and accrued expenses
 
20,389

 
53,537

Change in short term and long-term tax liabilities
 
(5,175
)
 
6,841

Net cash used in operating activities
 
(76,575
)
 
(27,958
)
INVESTING ACTIVITIES
 
 
 
 
Purchases of property and equipment
 
(22,635
)
 
(19,836
)
Proceeds from sale of business units, property and equipment
 
7,775

 
382

Purchase of intangible assets
 
(7,521
)
 
(12,023
)
Purchases of businesses, net of cash acquired
 
—

 
(57,486
)
Cash received for notes receivable
 
15

 
27

Net cash used in investing activities
 
(22,366
)
 
(88,936
)
FINANCING ACTIVITIES
 
 
 
 
Change in long-term debt
 
94,995

 
107,321

Common stock issued for exercise of options
 
1

 
1,290

Common stock repurchased
 
(5,000
)
 
(14,999
)
Payments to tax authorities for employee share-based compensation
 
(706
)
 
(141
)
Net cash provided by financing activities
 
89,290

 
93,471

Effect of foreign currency exchange rates on cash
 
(5,616
)
 
63

Net decrease in cash and cash equivalents
 
(15,267
)
 
(23,360
)
Cash, cash equivalents and restricted cash, beginning
 
229,876

 
117,623

Cash, cash equivalents and restricted cash, ending
 
$
214,609

 
$
94,263

For further information see Note 23 - Supplemental Cash Flow.
 
 
 
 








The accompanying notes are an integral part of these unaudited Consolidated Financial Statements.

9

JELD-WEN HOLDING, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Description of Company and Summary of Significant Accounting Policies
Nature of Business – JELD-WEN Holding, Inc., along with its subsidiaries, is a vertically integrated global manufacturer and distributor of windows and doors that derives substantially all of its revenues from the sale of its door and window products. Unless otherwise specified or the context otherwise requires, all references in these notes to “JELD-WEN,” “we,” “us,” “our,” or the “Company” are to JELD-WEN Holding, Inc. and its subsidiaries.
We have facilities located in the U.S., Canada, Europe, Australia, Asia, Mexico, and South America. Our products are marketed primarily under the JELD-WEN brand name in the U.S. and Canada and under JELD-WEN and a variety of acquired brand names in Europe, Australia, and Asia.
Our revenues are affected by the level of new housing starts and remodeling activity in each of our markets. Our sales typically follow seasonal new construction and repair and remodeling industry patterns. The peak season for home construction and remodeling in many of our markets generally corresponds with the second and third calendar quarters, and therefore, sales volume is typically higher during those quarters. Our first and fourth quarter sales volumes are generally lower due to reduced repair and remodeling activity and reduced activity in the building and construction industry as a result of colder and more inclement weather in certain of our geographic end markets.
Basis of Presentation – The accompanying unaudited consolidated financial statements as of March 28, 2020 and for the three months ended March 28, 2020 and March 30, 2019, respectively, have been prepared in accordance with GAAP for interim financial information and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the Company’s financial position for the periods presented. The results for the three months ended March 28, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2020, or any other period. The accompanying consolidated balance sheet as of December 31, 2019 was derived from audited financial statements included in the Company’s Form 10-K. The accompanying consolidated financial statements do not include all of the information and footnotes required by GAAP for annual financial statements. Accordingly, they should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019.
Certain prior year amounts have been reclassified to conform to current year presentation. The consolidated statements of operations and statements of cash flows have been revised to reflect the correction of certain errors and other accumulated misstatements as described in Note 25 - Revision of Prior Period Financial Statements. We do not believe the errors corrected were material to our previously issued financial statements.
All U.S. dollar and other currency amounts, except per share amounts, are presented in thousands unless otherwise noted.
Fiscal Year – We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more or fewer days included than a traditional 91-day fiscal quarter.
Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in the nature of these estimates.
Factoring Arrangements – Our ABS subsidiary, acquired in March 2018, has entered into factoring agreements with a U.S.-based financial institution under which it can elect to sell certain of its accounts receivable under non-recourse agreements. These transactions are treated as a sale and are accounted for as a reduction in accounts receivable because the agreements transfer effective control over and risk of non-collection to the factor. Thus, cash proceeds from these arrangements are reflected as operating activities, including the change of accounts receivable on our statement of cash flows each period. We do not service any factored accounts after the factoring has occurred and do not have any servicing assets or liabilities. We utilize factoring arrangements as part of our financing to manage working capital. The aggregate gross amount factored under these arrangements was $17.9 million and $19.0 million for the three months ended March 28,

10

2020 and March 30, 2019, respectively. The cost of factoring is reflected in the accompanying unaudited consolidated statements of operations as interest expense with other financing costs and was $0.1 million and $0.2 million for the three months ended March 28, 2020 and March 30, 2019, respectively.
Recently Adopted Accounting Standards – In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. To simplify the measurement of goodwill impairments, this ASU eliminates Step 2 from the goodwill impairment test, which required the calculation of the implied fair value of goodwill. Instead, under the amendments in this ASU, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. We adopted this standard in the first quarter of 2020 and the adoption did not have an impact on our unaudited consolidated financial statements as of the date of adoption.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard requires the measurement and recognition of expected credit losses for financial assets held at amortized cost and adds an impairment model that is based on expected losses rather than incurred losses. In April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to (Topic 326), Financial Instruments-Credit Losses, (Topic 815), Derivatives and Hedging, and (Topic 825), Financial Instruments, to clarify and address certain items related to the amendments of ASU No. 2016-13. We adopted this standard in the first quarter of 2020 using the modified retrospective approach, which primarily impacted our allowance for doubtful accounts as a result of our analysis of customer historical credit and collections data. Additionally, we recognized a $5.7 million cumulative effect adjustment, net of tax, to retained earnings, which includes a $7.6 million increase to the allowance for doubtful accounts and a $1.9 million net impact to deferred tax assets.
Recent Accounting Standards Not Yet Adopted – In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or by another reference rate expected to be discontinued. The amendments are effective for all entities as of March 12, 2020 through December 31, 2022. We are currently assessing the impact of this ASU on our consolidated financial statements and disclosures.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which removes certain exceptions to the general principles of ASC 740, including, but not limited to, accounting relating to intraperiod tax allocations, deferred tax liabilities related to outside basis differences, and year to date losses in interim periods. This guidance is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. We are currently assessing the impact of this ASU on our consolidated financial statements and disclosures.
In August 2018, the FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans, which adds, modifies and clarifies several disclosure requirements for employers that sponsor defined benefit pension or other post retirement plans. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We are currently assessing the effect that this ASU will have on our disclosures.
Note 2. Acquisitions
In March 2019, we acquired VPI Quality Windows, Inc (“VPI”). VPI is a leading manufacturer of vinyl windows, specializing in customized solutions for mid-rise multi-family, industrial, hospitality and commercial projects, primarily in the western U.S. VPI is located in Spokane, Washington and is a part of our North America segment.

11

The fair values of the assets and liabilities acquired of this acquisition are summarized below:
(amounts in thousands)
Preliminary Allocation
 
Measurement Period Adjustment
 
Final Allocation
Fair value of identifiable assets and liabilities:
 
 
 
 
 
Accounts receivable
$
11,417

 
$
(420
)
 
$
10,997

Inventories
2,555

 
(141
)
 
2,414

Other current assets
261

 
40

 
301

Property and equipment
3,166

 
176

 
3,342

Identifiable intangible assets
17,702

 
5,735

 
23,437

Operating lease assets
3,739

 
—

 
3,739

Goodwill
26,553

 
(3,053
)
 
23,500

Other assets
10

 
—

 
10

Total assets
$
65,403

 
$
2,337

 
$
67,740

Accounts payable
2,629

 
—

 
2,629

Other current liabilities
1,875

 
522

 
2,397

Operating lease liability
3,413

 
—

 
3,413

Other liabilities
—

 
1,502

 
1,502

Total liabilities
$
7,917

 
$
2,024

 
$
9,941

Purchase price:

 
 
 

Cash consideration, net of cash acquired
$
57,486

 
$
313

 
$
57,799


The final goodwill of $23.5 million, calculated as the excess of the purchase price over the fair value of net assets, represents operational efficiencies and sales synergies, and the full amount is expected to be tax-deductible. The intangible assets include customer relationships and tradenames and will be amortized over an estimated weighted average amortization period of 8 years. Acquisition-related costs are expensed as incurred and are included in selling, general and administrative expense in our accompanying unaudited consolidated statements of operations. We incurred acquisition-related costs of $0.2 million during the three months ended March 30, 2019. The purchase price allocation was considered complete as of March 28, 2020.
We evaluated this acquisition quantitatively and qualitatively and determined it to be insignificant. Therefore, certain pro forma disclosures under ASC 805-10-50 have been omitted.
The results of this acquisition are included in our unaudited consolidated financial statements from the date of acquisition.
Note 3. Accounts Receivable
We sell our manufactured products to a large number of customers, primarily in the residential housing construction and remodel sectors, broadly dispersed across many domestic and foreign geographic regions. We assess the credit risk relating to our accounts receivable based on quantitative and qualitative factors, primarily historical credit collections within each region where we have operations. We perform ongoing credit evaluations of our customers to minimize credit risk. We do not usually require collateral for accounts receivable but will require advance payment, guarantees, a security interest in the products sold to a customer, and/or letters of credit in certain situations. Customer accounts receivable converted to notes receivable are primarily collateralized by inventory or other collateral.
As of January 1, 2020, we adopted ASC 326 - Measurement of Credit Losses on Financial Instruments on a modified retrospective basis, which increased the allowance for doubtful accounts by $7.6 million on the date of adoption.
At March 28, 2020 and December 31, 2019, we had an allowance for doubtful accounts of $13.0 million and $6.0 million, respectively.

12

Note 4. Inventories
Inventories are stated at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs.
(amounts in thousands)
March 28,
2020
 
December 31,
2019
Raw materials
$
367,321

 
$
372,289

Work in process
37,371

 
38,432

Finished goods
119,330

 
94,357

Total inventories
$
524,022

 
$
505,078


Note 5. Property and Equipment, Net
(amounts in thousands)
March 28,
2020
 
December 31,
2019
Property and equipment
$
1,999,308

 
$
2,052,584

Accumulated depreciation
(1,169,578
)
 
(1,188,209
)
Total property and equipment, net
$
829,730

 
$
864,375


We monitor all property and equipment for any indicators of potential impairment and recorded impairment charges of $0.9 million and $0.9 million during the three months ended March 28, 2020 and March 30, 2019, respectively.
Depreciation expense was recorded as follows:
 
Three Months Ended
(amounts in thousands)
March 28,
2020
 
March 30,
2019
Cost of sales
$
21,741

 
$
20,669

Selling, general and administrative
2,629

 
2,407

Total depreciation expense
$
24,370

 
$
23,076


Note 6. Goodwill
The following table summarizes the changes in goodwill by reportable segment:
(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Total
Reportable
Segments
Balance as of January 1
$
247,502

 
$
273,912

 
$
81,086

 
$
602,500

Currency translation
(448
)
 
(4,552
)
 
(10,457
)
 
(15,457
)
Balance at end of period
$
247,054

 
$
269,360

 
$
70,629

 
$
587,043



13

Note 7. Intangible Assets, Net
The cost and accumulated amortization values of our intangible assets were as follows:
 
March 28, 2020
(amounts in thousands)
Cost
 
Accumulated
Amortization
 
Net
Book Value
Customer relationships and agreements
$
148,025

 
$
(59,049
)
 
$
88,976

Software
94,244

 
(19,645
)
 
74,599

Trademarks and trade names
54,613

 
(7,729
)
 
46,884

Patents, licenses and rights
40,710

 
(13,936
)
 
26,774

Total amortizable intangibles
$
337,592

 
$
(100,359
)
 
$
237,233

 
December 31, 2019
(amounts in thousands)
Cost
 
Accumulated
Amortization
 
Net
Book Value
Customer relationships and agreements
$
151,540

 
$
(57,326
)
 
$
94,214

Software
92,821

 
(18,222
)
 
74,599

Trademarks and trade names
58,088

 
(7,512
)
 
50,576

Patents, licenses and rights
45,392

 
(14,454
)
 
30,938

Total amortizable intangibles
$
347,841

 
$
(97,514
)
 
$
250,327


At March 28, 2020, we have capitalized software costs of $62.3 million related to the application development stage of our global ERP system implementation, including $5.4 million during the three months ended March 28, 2020. As of March 28, 2020, we have placed $52.0 million in service and are amortizing the cost of our global ERP system over its estimated useful life of 15 years. In March 2020, we impaired $3.4 million of capitalized software due to delays in implementation of certain ERP modules and the uncertainty of its future.
Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of such assets may not be recoverable. Intangible assets that become fully amortized are removed from the accounts in the period that they become fully amortized. Amortization expense was recorded as follows:
 
Three Months Ended
(amounts in thousands)
March 28, 2020
 
March 30, 2019
Amortization expense
$
6,603

 
$
5,663


Note 8. Other Assets
(amounts in thousands)
March 28, 2020
 
December 31, 2019
Cloud computing arrangements
$
8,688

 
$
6,374

Customer displays
8,526

 
11,213

Deposits
6,270

 
6,440

Long-term notes receivable
4,549

 
4,614

Overfunded pension benefit obligation
1,784

 
2,015

Other prepaid expenses
1,319

 
1,896

Debt issuance costs on unused portion of revolver facility
1,014

 
1,472

Other long-term accounts receivable
634

 
563

Other long-term assets
355

 
375

Total other assets
$
33,139

 
$
34,962



14

Note 9. Accrued Expenses and Other Current Liabilities
(amounts in thousands)
March 28, 2020
 
December 31, 2019
Current portion of legal claims provision
$
83,093

 
$
79,332

Accrued sales and advertising rebates
50,255

 
67,250

Current portion of operating lease liability
42,860

 
45,254

Non-income related taxes
22,523

 
23,178

Accrued expenses
22,470

 
27,993

Current portion of warranty liability (Note 10)
20,397

 
21,054

Accrued interest payable
16,790

 
2,126

Current portion of accrued claim costs relating to self-insurance programs
11,894

 
12,312

Current portion of deferred revenue
8,581

 
7,986

Current portion of restructuring accrual (Note 17)
4,946

 
6,051

Current portion of derivative liability (Note 19)
1,667

 
4,068

Current portion of accrued income taxes payable
1,845

 
1,999

Total accrued expenses and other current liabilities
$
287,321

 
$
298,603


The legal claims provision relates primarily to contingencies associated with the ongoing legal matters disclosed in Note 21 - Commitments and Contingencies.
The accrued sales and advertising rebates, accrued interest payable, and non-income related taxes can fluctuate significantly period-over-period due to timing of payments.
The prior period information has been revised. Please refer to Note 25 - Revision of Prior Period Financial Statements.
Note 10. Warranty Liability
Warranty terms vary from one year to lifetime on certain window and door components. Warranties are normally limited to servicing or replacing defective components for the original customer. Product defects arising within six months of sale are classified as manufacturing defects and are not included in the current period expense below. Some warranties are transferable to subsequent owners and are either limited to 10 years from the date of manufacture or require pro-rata payments from the customer. A provision for estimated warranty costs is recorded at the time of sale based on historical experience and is periodically adjusted to reflect actual experience.
An analysis of our warranty liability is as follows:
(amounts in thousands)
March 28, 2020
 
March 30, 2019
Balance as of January 1
$
49,716

 
$
46,468

Current period expense
4,668

 
4,344

Liabilities assumed due to acquisition
—

 
79

Experience adjustments
1,902

 
904

Payments
(6,476
)
 
(5,602
)
Currency translation
(756
)
 
106

Balance at period end
49,054

 
46,299

Current portion
(20,397
)
 
(20,272
)
Long-term portion
$
28,657

 
$
26,027


The most significant component of our warranty liability is in the North America segment, which totaled $44.4 million at March 28, 2020, after discounting future estimated cash flows at rates between 0.76% and 4.75%. Without discounting, the liability would have been higher by approximately $3.0 million.

15

Note 11. Long-Term Debt
Our long-term debt, net of original issue discount and unamortized debt issuance costs, consisted of the following:
 
March 28, 2020
 
March 28,
2020
 
December 31,
2019
(amounts in thousands)
Interest Rate
 
 
Senior notes
4.63% - 4.88%
 
$
800,000

 
$
800,000

Term loans
1.30% - 3.94%
 
586,446

 
591,153

Finance leases and other financing arrangements
1.90% - 6.00%
 
108,759

 
108,613

Mortgage notes
1.65%
 
27,361

 
28,175

Revolving credit facilities
2.25% -2.55%
 
100,000

 
—

Installment notes for stock
—%
 
—

 
205

Unamortized debt issuance costs and original issue discount
 
(10,711
)
 
(10,774
)
 
 
 
1,611,855

 
1,517,372

Current maturities of long-term debt
 
(64,740
)
 
(65,846
)
Long-term debt
 
$
1,547,115

 
$
1,451,526

Summaries of our significant changes to outstanding debt agreements as of March 28, 2020 are as follows:
Senior Notes
In December 2017, we issued $800.0 million of unsecured Senior Notes in two tranches: $400.0 million bearing interest at 4.63% and maturing in December 2025, and $400.0 million bearing interest at 4.88% and maturing in December 2027 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act.
Term Loans
U.S. Facility - In February 2019, we purchased interest rate caps in order to effectively fix a 3.0% per annum ceiling on the LIBOR component of an aggregate $150 million of our term loans. The caps became effective March 29, 2019 and expire December 31, 2021.
In September 2019, we amended the Term Loan Facility to provide for an incremental aggregate principal amount of $125.0 million and used the proceeds primarily to repay $115.0 million of outstanding borrowings under the ABL Facility. The proceeds were net of the original issue discount of 0.5%, or $0.6 million, as well as $0.6 million in fees and expenses associated with the debt issuance. This amendment requires that approximately $1.4 million of the aggregate principal amount be repaid quarterly until the maturity date. There were no other changes to key terms and the facility maintains its original maturity date in December 2024. At March 28, 2020, the outstanding principal balance, net of original issue discount, was $555.0 million.
Australia Facility - In June 2019, we reallocated AUD 5.0 million from the term loan commitment to the interchangeable commitment of the Australia Senior Secured Credit Facility. The amended AUD 50.0 million floating rate term loan facility bears interest at a base rate of BBSY plus a margin ranging from 1.00% to 1.10%, includes a line fee of 1.25% on the commitment amount, and matures in February 2023. This facility had an outstanding principal balance of $30.3 million as of March 28, 2020.
Revolving Credit Facilities
ABL Facility - In December 2019, we amended our ABL facility to reflect current banking regulatory requirements, which do not have a financial impact. In March 2020, we drew $100.0 million under our ABL Facility as a precautionary measure to ensure funding of our seasonal working capital cash requirements given the recent significant impact on global financial markets and economies as a result of the COVID-19 pandemic. As of March 28, 2020, we had $100.0 million in borrowings, $35.6 million in letters of credit and $204.0 million available under the ABL Facility.
Australia Senior Secured Credit Facility - In June 2019, we amended the Australia Senior Secured Credit Facility, reallocating availability from the Australia Term Loan Facility and collapsing the floating rate revolving loan facility into a AUD 35.0 million interchangeable facility to be used for guarantees, asset financing, and loans of 12 months or less bearing interest at BBSY plus a margin of 1.10% and a line fee of 0.50%, compared to BBSY plus a margin of 0.75% and a line fee of 1.15% on the revolving facility limit under the previous amendment. The non-term loan portion of the Australia

16

Senior Secured Credit Facility no longer has a set maturity date but is instead subject to an annual review. As of March 28, 2020, we had AUD 21.3 million ($12.9 million) available under this facility.
At March 28, 2020, we had combined borrowing availability of $216.9 million under our revolving credit facilities.
Mortgage Notes – In December 2007, we entered into thirty-year mortgage notes secured by land and buildings with principal payments which began in 2018. At March 28, 2020, we had DKK 185.2 million (or $27.4 million) outstanding under these notes.
Finance leases and other financing arrangements – In addition to finance leases, we include insurance premium financing arrangements and loans secured by equipment in this category. At March 28, 2020, we had $108.8 million outstanding in this category, with maturities ranging from 2020 to 2027.
As of March 28, 2020, we were in compliance with the terms of all of our credit facilities.
Note 12. Income Taxes

The Company has completed its accounting for the income tax effects of the Tax Act. Although the measurement period has effectively ended, additional guidance and regulations continue to be released or finalized. We have considered these ongoing developments and determined that they have no impact on our tax accounts for the three months ended March 28, 2020. Final guidance, once issued, may materially affect our conclusions regarding the net related effects of the Tax Act on our unaudited consolidated financial statements. Until then, management will continue to monitor and work with its tax advisors to interpret any guidance issued.

The effective income tax rate for continuing operations 123.8% for the three months ended March 28, 2020 compared to 39.6% for the three months ended March 30, 2019. In accordance with ASC 740-270, we recorded tax expense of $1.2 million and $10.3 million from continuing operations for the three months ended March 28, 2020 and March 30, 2019, respectively, by applying an estimated annual effective tax rate to our year-to-date income for includable entities during the respective periods. Our estimated annual effective tax rate for both years includes the impact of the tax on GILTI. The application of the estimated annual effective tax rate in interim periods may result in a significant variation in the customary relationship between income tax expense and pretax accounting income due to the seasonality of our global business. Entities that are currently generating losses and for which there is a full valuation allowance are excluded from the worldwide effective tax rate calculation and are calculated separately. The estimated annual effective tax rate for the current year is materially impacted by changes in management’s judgment regarding the realizability of deferred tax assets. Due to the ongoing financial and operational impacts on our business arising from COVID-19 focused in the current year, our ability to realize certain tax benefits related primarily to US foreign tax credits has been impacted. As such, management believes that our existing valuation allowance against these credits as well as our net operating losses at the state level will likely increase through the year as events occur. In accordance with guidance, we have factored the predicted increases as of the balance sheet date into our estimated annual effective tax rate for the current year. To the extent that actual results and/or events differ from our predicted results, we may continue to see effects on our estimated annual effective tax rate.

The impact of significant discrete items is separately recognized in the quarter in which they occur. The tax expense related to discrete items included in the tax provision for continuing operations for the three months ended March 28, 2020 and March 30, 2019 was $0.8 million and $1.3 million, respectively. The discrete tax expense of $0.8 million for the three months ended March 28, 2020 was attributable to current period interest expense on uncertain tax positions. The discrete tax expense for the three months ended March 30, 2019 was comprised primarily of $1.1 million of tax expense related to the shortfall recognized from exercises and forfeitures from share-based compensation awards and $0.4 million attributable to current period interest expense on uncertain tax positions, offset by $0.2 million for other matters.

Under ASC 740-10, we provide for uncertain tax positions and the related interest expense by adjusting unrecognized tax benefits and accrued interest accordingly. We recognize potential interest and penalties related to unrecognized tax benefits in income tax expense. We had unrecognized tax benefits of $19.8 million and $20.2 million as of March 28, 2020 and December 31, 2019, respectively.

The prior period information has been revised. Please refer to Note 25 - Revision of Prior Period Financial Statements.



17

Note 13. Segment Information
We report our segment information in the same way management internally organizes the business in assessing performance and making decisions regarding allocation of resources in accordance with ASC 280-10- Segment Reporting. We determined that we have three reportable segments, organized and managed principally by geographic region. Our reportable segments are North America, Europe and Australasia. We report all other business activities in Corporate and unallocated costs. Factors considered in determining the three reportable segments include the nature of business activities, the management structure accountable directly to the CODM, the discrete financial information available and the information regularly reviewed by the CODM. Management reviews net revenues and Adjusted EBITDA to evaluate segment performance and allocate resources. We define Adjusted EBITDA as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity earnings of non-consolidated entities; income tax (benefit) expense; depreciation and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation expense; non-cash foreign exchange transaction/translation (income) loss; other non-cash items; other items; and costs related to debt restructuring and debt refinancing.
The following tables set forth certain information relating to our segments’ operations:
(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Total Operating
Segments
 
Corporate
and
Unallocated
Costs
 
Total
Consolidated
Three Months Ended March 28, 2020
 
 
 
 
 
 
 
 
 
 
Total net revenues
$
587,048

 
$
281,807

 
$
112,972

 
$
981,827

 
$
—

 
$
981,827

Intersegment net revenues
(312
)
 
(314
)
 
(2,014
)
 
(2,640
)
 
—

 
(2,640
)
Net revenues from external customers
$
586,736

 
$
281,493

 
$
110,958

 
$
979,187

 
$
—

 
$
979,187

Impairment and restructuring charges
943

 
2,001

 
264

 
3,208

 
3,337

 
6,545

Adjusted EBITDA
48,990

 
23,326

 
8,725

 
81,041

 
(6,533
)
 
74,508

Three Months Ended March 30, 2019
 
 
 
 
 
 
 
 
 
 
Total net revenues
$
565,701

 
$
299,993

 
$
146,520

 
$
1,012,214

 
$
—

 
$
1,012,214

Intersegment net revenues
(596
)
 
(27
)
 
(1,331
)
 
(1,954
)
 
—

 
(1,954
)
Net revenues from external customers
$
565,105

 
$
299,966

 
$
145,189

 
$
1,010,260

 
$
—

 
$
1,010,260

Impairment and restructuring charges
1,958

 
1,309

 
465

 
3,732

 
(13
)
 
3,719

Adjusted EBITDA
52,796

 
27,638

 
16,380

 
96,814

 
(7,536
)
 
89,278


Reconciliations of net income (loss) to Adjusted EBITDA are as follows:
 
Three Months Ended
(amounts in thousands)
March 28, 2020
 
March 30, 2019
Net income (loss)
$
(230
)
 
$
15,777

Income tax expense
1,197

 
10,349

Depreciation and amortization
33,446

 
30,898

Interest expense, net
16,604

 
17,656

Impairment and restructuring charges(1)
6,695

 
4,103

(Gain) loss on sale of property and equipment
(2,073
)
 
512

Share-based compensation expense
3,733

 
2,596

Non-cash foreign exchange transaction/translation (income) loss
(1,189
)
 
(3,686
)
Other items (2)
16,325

 
10,408

Other non-cash items
—

 
665

Adjusted EBITDA
$
74,508

 
$
89,278


18

(1)
Impairment and restructuring charges consist of (i) impairment and restructuring charges that are included in our consolidated unaudited statements of operations plus (ii) additional charges relating to inventory and/or manufacturing of our products that are included in cost of sales in the accompanying unaudited consolidated statements of operations in the amount of $150 and $384 for the three months ended March 28, 2020 and March 30, 2019, respectively. For further explanation of impairment and restructuring charges that are included in our consolidated statements of operations, see Note 17 - Impairment and Restructuring Charges in our financial statements.
(2)
Other non-recurring items not core to ongoing business activity include: (i) in the three months ended March 28, 2020 (1) $11,706 in legal costs and professional expenses relating primarily to litigation, (2) $3,110 in facility closure and consolidation costs related to our facility footprint rationalization program, and (3) $1,235 in one-time lease termination charges; and (ii) in the three months ended March 30, 2019, (1) $4,827 in facility closure and consolidation costs related to our facility footprint rationalization program, (2) $2,934 in acquisition and integration costs, and (3) $1,648 in legal costs and professional expenses relating primarily to litigation.
The prior period information has been revised and reclassified to conform with current period presentation. Please refer to Note 25 - Revision of Prior Period Financial Statements.
Note 14. Capital Stock
Preferred Stock - Our Board of Directors is authorized to issue Preferred Stock from time to time in one or more series and with such rights, privileges, and preferences as the Board of Directors shall from time to time determine. We have not issued any shares of preferred stock.
Common Stock - Common Stock includes the basis of shares outstanding plus amounts recorded as additional paid-in capital. Shares outstanding exclude the shares issued to the Employee Benefit Trust that are considered similar to treasury shares and total 193,941 shares at both March 28, 2020 and December 31, 2019 with a total original issuance value of $12.4 million.
We record share repurchases on their trade date and reduce shareholders’ equity and increase accounts payable. Repurchased shares are retired, and the excess of the repurchase price over the par value of the shares is charged to retained earnings.
In April 2018, our Board of Directors authorized the repurchase of up to $250.0 million of our Common Stock through December 2019.
On November 4, 2019, the Board of Directors authorized an increase to the remaining authorization under the share repurchase program to a total of $175.0 million with no expiration date. As of March 28, 2020, $170.0 million was remaining under the repurchase authorization.
During the three months ended March 28, 2020 and March 30, 2019, we repurchased 265,589 and 939,798 shares, respectively, of our Common Stock for aggregate consideration of $5.0 million and $15.0 million, respectively.
Note 15. Earnings Per Share
The basic and diluted income (loss) per share calculations were determined based on the following share data:
 
Three Months Ended
 
March 28, 2020
 
March 30, 2019
Weighted average outstanding shares of Common Stock basic
100,646,850

 
100,643,509

Restricted stock units, performance share units and options to purchase Common Stock
—

 
817,784

Weighted average outstanding shares of Common Stock diluted
100,646,850

 
101,461,293


For the three months ended March 28, 2020, we had net losses from operations. As a result, no potentially dilutive securities were included in the denominator for computing diluted loss per share as their inclusion would be anti-dilutive.
The following table provides the securities that could potentially dilute basic earnings per share in the future but were not included in the computation of diluted income (loss) per share as their inclusion would be anti-dilutive:

19

 
Three Months Ended
 
March 28, 2020
 
March 30, 2019
Common Stock options
2,170,131
 
1,685,101
Restricted stock units
670,493
 
449,547
Performance share units
206,263
 
147,552

Note 16. Stock Compensation

The activity under our incentive plans for the periods presented are reflected in the following tables:
 
Three Months Ended
 
March 28, 2020
 
March 30, 2019
 
Shares
 
Weighted Average Exercise Price Per Share
 
Shares
 
Weighted Average Exercise Price Per Share
Options granted
400,994

 
$
24.54

 
424,944

 
$
20.94

Options canceled
41,489

 
$
25.15

 
108,337

 
$
23.81

Options exercised
95,438

 
$
11.89

 
203,545

 
$
7.80

 
 
 
 
 
 
 
 
 
Shares

 
Weighted Average Grant Date Fair Value
 
Shares

 
Weighted Average Grant Date Fair Value
RSUs granted
701,727

 
$
18.67

 
573,815

 
$
20.94

PSUs granted
305,100

 
$
25.50

 
387,568

 
$
20.94



Stock-based compensation expense was $3.7 million and $2.6 million for the three months ended March 28, 2020 and March 30, 2019, respectively. As of March 28, 2020, we had $42.2 million of total unrecognized compensation expense related to non-vested share-based compensation arrangements. This cost is expected to be recognized over the remaining weighted-average vesting period of 2.32 years.
Note 17. Impairment and Restructuring Charges
During 2020 and 2019, we engaged in restructuring activities intended to improve productivity, operating margins, and working capital levels. Restructuring costs primarily relate to workforce reductions, repositioning of management structure and costs associated with plant consolidations and closures.
Asset impairment charges were recorded in addition to our restructuring costs. In the three months ended March 28, 2020, impairment charges primarily related to capitalized costs of certain ERP modules due to delays in implementation and uncertainty of their future use. In the three months ended March 30, 2019, impairment charges were primarily related to ROU assets and property and equipment held by operations impacted by restructuring.
The following table summarizes the restructuring charges for the periods indicated:

20

(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Corporate
and
Unallocated
Costs
 
Total
Consolidated
Three Months Ended March 28, 2020
 
 
 
 
 
 
 
 
Severance costs
$
944

 
$
911

 
$
47

 
$
(10
)
 
$
1,892

Other exit costs
(1
)
 
195

 
217

 
(12
)
 
399

Total restructuring costs
943

 
1,106

 
264

 
(22
)
 
2,291

Impairments
—

 
895

 
—

 
3,359

 
4,254

Total impairment and restructuring charges
$
943

 
$
2,001

 
$
264

 
$
3,337

 
$
6,545

Three Months Ended March 30, 2019
 

 

 

 

Severance costs
$
531

 
$
1,148

 
$
199

 
$
—

 
$
1,878

Other exit costs
(4
)
 
—

 
224

 
(13
)
 
207

Total restructuring costs
527

 
1,148

 
423

 
(13
)
 
2,085

Impairments
1,431

 
161

 
42

 
—

 
1,634

Total impairment and restructuring charges
$
1,958

 
$
1,309

 
$
465

 
$
(13
)
 
$
3,719


Short-term restructuring accruals are recorded in accrued expenses and totaled $4.9 million and $6.1 million as of March 28, 2020 and December 31, 2019, respectively. Long-term restructuring accruals are recorded in deferred credits and other liabilities and totaled $0.8 million and $1.0 million as of March 28, 2020 and December 31, 2019, respectively.
The following is a summary of the restructuring accruals recorded and charges incurred:
(amounts in thousands)
Beginning
Accrual
Balance
 
Additions
Charged to
Expense
 
Payments
or
Utilization
 
Ending
Accrual
Balance
March 28, 2020
 
 
 
 
 
 
 
Severance costs
$
5,314

 
$
1,892

 
$
(3,450
)
 
$
3,756

Other exit costs
1,729

 
399

 
(156
)
 
1,972

Total
$
7,043

 
$
2,291

 
$
(3,606
)
 
$
5,728

March 30, 2019
 
 
 
 
 
 
 
Severance costs
$
5,353

 
$
1,878

 
$
(4,003
)
 
$
3,228

Other exit costs
3,287

 
207

 
(411
)
 
3,083

Total
$
8,640

 
$
2,085

 
$
(4,414
)
 
$
6,311


The prior period information has been reclassified to conform to current period presentation.

Note 18. Other (Income) Expense
The table below summarizes the amounts included in other (income) expense in the accompanying unaudited consolidated statements of operations:
 
Three Months Ended
(amounts in thousands)
March 28, 2020
 
March 30, 2019
Pension benefit expense
$
2,787

 
$
2,748

Foreign currency gain
(2,250
)
 
(5,295
)
(Gain) loss on sale of business units, property, and equipment
(2,073
)
 
582

Other income items
(795
)
 
(260
)
Legal settlement income
—

 
(1,247
)
Total other income
$
(2,331
)
 
$
(3,472
)


21

The prior period information has been revised and reclassified to conform to current period presentation. Please refer to Note 25 - Revision of Prior Period Financial Statements.
Note 19. Derivative Financial Instruments
All derivatives are recorded as assets or liabilities in the consolidated balance sheets at their respective fair values. For derivatives that qualify for hedge accounting, changes in the fair value related to the effective portion of the hedge are recognized in earnings at the same time as either the change in fair value of the underlying hedged item or the effect of the hedged item’s exposure to the variability of cash flows. Changes in fair value related to the ineffective portion of the hedge are recognized immediately in earnings. Changes in the fair value of derivatives that do not qualify for hedge accounting, or fail to meet the criteria, thereafter, are also recognized in the consolidated statements of operations. See Note 20 - Fair Value of Financial Instruments for additional information on the fair value of our derivative assets and liabilities.
Foreign currency derivatives – We are exposed to the impact of foreign currency fluctuations in certain countries in which we operate. In most of these countries, the exposure to foreign currency movements is limited because the operating revenues and expenses of our business units are substantially denominated in the local currency. To the extent borrowings, sales, purchases or other transactions are not executed in the local currency of the operating unit, we are exposed to foreign currency risk. To mitigate the exposure, we enter into a variety of foreign currency derivative contracts, such as forward contracts, option collars, and cross-currency hedges. We use foreign currency derivative contracts, with a total notional amount of $111.6 million, to manage the effect of exchange fluctuations on forecasted sales, purchases, acquisitions, inventory and capital expenditures and certain intercompany transactions that are denominated in foreign currencies. We use foreign currency derivative contracts, with a total notional amount of $30.0 million, to hedge the effects of translation gains and losses on intercompany loans and interest. We also use foreign currency derivative contracts, with a total notional amount of $112.1 million, to mitigate the impact to the consolidated earnings of the Company from the effect of the translation of certain subsidiaries’ local currency results into U.S. dollars. We do not use derivative financial instruments for trading or speculative purposes. We have not elected hedge accounting for any foreign currency derivative contracts. We record mark-to-market changes in the values of these derivatives in other (income) expense. We recorded mark-to-market gain of $15.8 million and loss of $3.3 million in the three months ended March 28, 2020 and March 30, 2019, respectively.
Interest rate derivatives – We are exposed to interest rate risk in connection with our variable rate long-term debt and partially mitigate this risk through interest rate derivatives such as swaps and caps. In conjunction with the December 2017 refinancing of the Term Loan Facility (see Note 11 - Long-Term Debt), we terminated all of the interest rate swaps which had outstanding notional amounts aggregating to $914.3 million and recorded a loss on termination of $3.6 million in consolidated other comprehensive income (loss), which was being amortized as interest expense over the pre-termination life of the interest rate swaps. As of December 31, 2019, the loss on termination has been fully amortized. We recorded interest expense deriving from the amortization of the loss on termination of interest rate swaps of $0.4 million during the three months ended March 30, 2019.
During the first quarter of 2019, we entered into two interest rate cap contracts against three-month U.S.-dollar LIBOR, each with a cap rate of 3.00%. These caps have a combined notional amount of $150.0 million, were effective as of March 2019, and terminate in December 2021. We have not elected hedge accounting and have recorded insignificant mark-to-market adjustments in the three months ended March 28, 2020 and March 30, 2019.
The fair values of derivative instruments held are as follows:
 
Derivative assets
(amounts in thousands)
Balance Sheet Location
 
March 28,
2020
 
December 31,
2019
Derivatives not designated as hedging instruments:
 
 
 
 
Foreign currency forward contracts
Other current assets
 
$
14,612

 
$
1,372

Interest rate cap contracts
Other assets
 
—

 
6

 
Derivatives liabilities
(amounts in thousands)
Balance Sheet Location
 
March 28,
2020
 
December 31,
2019
Derivatives not designated as hedging instruments:
 
 
 
 
Foreign currency forward contracts
Accrued expenses and other current liabilities
 
$
1,667

 
$
4,068



22

Note 20. Fair Value of Financial Instruments
We record financial assets and liabilities at fair value based on FASB guidance related to fair value measurements. The guidance requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Three levels of inputs may be used to measure fair value:
Level 1 – Quoted prices in active markets for identical assets or liabilities.
Level 2 – Quoted market-based inputs or unobservable inputs that are corroborated by market data.
Level 3 – Unobservable inputs that are not corroborated by market data.
The recorded carrying amounts and fair values of these instruments were as follows:
 
March 28, 2020
(amounts in thousands)
Carrying Amount
 
Total
Fair Value
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
 
Cash equivalents
$
70,011

 
$
70,011

 
$
—

 
$
70,011

 
$
—

Derivative assets, recorded in other current assets
14,612

 
14,612

 
—

 
14,612

 
—

Liabilities:
 
 
 
 
 
 
 
 
 
Senior notes
$
800,000

 
$
709,000

 
$
—

 
$
709,000

 
$
—

Term loans
586,445

 
517,000

 
—

 
517,000

 
—

Derivative liabilities, recorded in accrued expenses and deferred credits
1,667

 
1,667

 
—

 
1,667

 
—

 
December 31, 2019
(amounts in thousands)
Carrying Amount
 
Total
Fair Value
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
 
Derivative assets, recorded in other current assets
1,372

 
1,372

 
—

 
1,372

 
—

Liabilities:
 
 
 
 
 
 
 
 
 
Senior notes, recorded in long-term debt
$
800,000

 
$
823,500

 
$
—

 
$
823,500

 
$
—

Term loans, recorded in long-term debt and current maturities of long-term debt
591,153

 
593,932

 
—

 
593,932

 
—

Derivative liabilities, recorded in accrued expenses and deferred credits
4,068

 
4,068

 
—

 
4,068

 
—


Derivative assets and liabilities reported in level 2 include foreign currency and interest rate cap contracts. See Note 19- Derivative Financial Instruments for additional information about our derivative assets and liabilities.
The non-financial assets that are measured at fair value on a non-recurring basis are presented below:
 
March 28, 2020
(amounts in thousands)
Carrying Value
 
Total
Fair Value
 
Level 1
 
Level 2
 
Level 3
 
Total Losses
Continuing operations
$
341

 
$
341

 
$
—

 
$
—

 
$
341

 
$
895

Total
$
341

 
$
341

 
$
—

 
$
—

 
$
341

 
$
895


23

 
December 31, 2019
(amounts in thousands)
Carrying Value
 
Total
Fair Value
 
Level 1
 
Level 2
 
Level 3
 
Total Losses
Closed operations
$
988

 
988

 
$
—

 
$
—

 
$
988

 
$
1,586

Total
$
988

 
$
988

 
$
—

 
$
—

 
$
988

 
$
1,586



Note 21. Commitments and Contingencies
Litigation – We are involved in various legal proceedings, claims, and government audits arising in the ordinary course of business. We record our best estimate of a loss when the loss is considered probable and the amount of such loss can be reasonably estimated. When a loss is probable and there is a range of estimated loss with no best estimate within the range, we record the minimum estimated liability related to the lawsuit or claim. As additional information becomes available, we reassess the potential liability and revise our accruals, if necessary. Because of uncertainties related to the resolution of lawsuits and claims, the ultimate outcome may differ materially from our estimates.
Other than the matters described below, as of March 28, 2020, there are no current proceedings or litigation matters involving the Company or its property that we believe would have a material adverse effect on our consolidated financial position or cash flows, although they could have a material adverse effect on our operating results for a particular reporting period.
Steves & Sons, Inc. vs JELD-WEN – We sell molded door skins to certain customers pursuant to long-term contracts, and these customers in turn use the molded door skins to manufacture interior doors and compete directly against us in the marketplace. We gave notice of termination of one of these contracts and, on June 29, 2016, the counterparty to the agreement, Steves and Sons, Inc. (“Steves”) filed a claim against JWI in the U.S. District Court for the Eastern District of Virginia, Richmond Division (“Eastern District of Virginia”). The complaint alleged that our acquisition of CMI, a competitor in the molded door skins market, together with subsequent price increases and other alleged acts and omissions, violated antitrust laws, and constituted a breach of contract and breach of warranty. Specifically, the complaint alleged that our acquisition of CMI substantially lessened competition in the molded door skins market. The complaint sought declaratory relief, ordinary and treble damages, and injunctive relief, including divestiture of certain assets acquired in the CMI acquisition.
In February 2018, a jury in the Eastern District of Virginia returned a verdict that was unfavorable to JWI with respect to Steves’ claims that our acquisition of CMI violated Section 7 of the Clayton Act and found that JWI breached the supply agreement between the parties. The verdict awarded Steves $12.2 million for past damages under both the Clayton Act and breach of contract claims and $46.5 million in future lost profits under the Clayton Act claim.
On March 13, 2019, the presiding judge entered an Amended Final Judgment Order awarding $36.5 million in past damages under the Clayton Act (representing a trebling of the jury’s verdict) and granting divestiture of CMI, subject to appeal. The judgment also conditionally awarded damages in the event the judgment is overturned on appeal. Specifically, the court awarded $139.4 million as future antitrust damages in the event the divestiture order is overturned on appeal and $9.9 million as past contract damages in the event both the divestiture and antitrust claims are overturned on appeal.
JELD-WEN filed a supersedeas bond and notice of appeal of the judgment, which is scheduled for hearing by the Fourth Circuit Court of Appeals in May 2020, but could be rescheduled to a later date due to the COVID-19 pandemic.
On April 12, 2019, the plaintiffs filed a petition requesting an award of their fees and a bill of costs seeking $28.4 million in attorneys’ fees and $1.7 million in costs. That petition remains pending and subject to further appeal. On November 19, 2019, the presiding judge entered an order for further relief awarding Steves an additional $7.1 million in damages for pricing differences from the date of the underlying jury verdict through May 31, 2019. We have also appealed that ruling. On April 14, 2020, Steves filed a motion for further supplemental relief for pricing differences from the date of the prior order through the present. We are in the process of reviewing that new motion and are in the process of filing a responsive pleading. No hearing date on the new motion has been set.
We continue to believe that Steves’ claims lack merit, Steves’ damages calculations are speculative and excessive, and Steves is not entitled in any event to the extraordinary remedy of divestiture of CMI. We believe that multiple pretrial and trial rulings were erroneous and improperly limited the Company’s defenses, and that the judgment in accordance with the verdict was improper for several reasons under applicable law. The judgment, if ultimately upheld after exhaustion of our appellate remedies, could have a material adverse effect on our financial position, operating results, or cash flows, particularly for the reporting period in which a loss is recorded or a payment is required. Because the operations acquired

24

from CMI have been fully integrated into the Company’s operations, divestiture of those operations would be difficult if not impossible and, therefore, it is not possible to estimate the cost of any final divestiture order or the extent to which such an order would have a material adverse effect on our financial position, operating results or cash flows.
During the course of the proceedings in the Eastern District of Virginia, we discovered certain facts that led us to conclude that Steves, its principals and certain former employees of the Company had misappropriated Company trade secrets, violated the terms of various agreements between the Company and those parties, and violated other laws. On May 11, 2018, a jury in the Eastern District of Virginia returned a verdict on our trade secrets claims against Steves and awarded damages in the amount of $1.2 million. The presiding judge entered a judgment in our favor for those damages and the entire amount has been paid by Steves. On August 16, 2019, the presiding judge granted Steves’ request for an injunction, prohibiting us from pursuing certain claims against individual defendants pending in Bexar County, Texas. These claims have been stayed pending appeal.
Separately, on February 14, 2020, Steves filed a complaint and motion for preliminary injunction in the U.S. District Court for the Eastern District of Virginia, Richmond Division, alleging that we breached the long-term supply agreement between the parties, among other claims, including by incorrectly calculating the allocation of door skins owed to Steves. Steves is seeking an additional allotment of door skins and damages for violation of antitrust laws, tortious interference, and breach of contract. On April 10, 2020, the presiding judge granted Steves’ motion for preliminary injunction and the parties settled the issues underlying the preliminary injunction on April 30, but reserved the right to appeal the ruling in the Fourth Circuit Court of Appeals. The Company believes all the claims lack merit and has moved to dismiss the antitrust and tortious interference claims. A trial on this matter is currently expected in July 2020.
Cambridge Retirement System v. JELD-WEN Holding, Inc., et al. – On February 19, 2020, Cambridge Retirement System filed a putative class action lawsuit in the U.S. District Court for the Eastern District of Virginia against the Company, current and former Company executives and various Onex-related entities alleging violations of Section 10(b) and Rule 10b-5 of the Exchange Act, as well as violations of Section 20(a) of the Exchange Act against the individual defendants and Onex-related entities.  The lawsuit seeks compensatory damages, equitable relief and an award of attorneys’ fees and costs. The Company believes the claims lack merit and intends to vigorously defend against the action. 
In Re: Interior Molded Doors Antitrust Litigation – On October 19, 2018, Grubb Lumber Company, on behalf of itself and others similarly situated, filed a putative class action lawsuit against us and one of our competitors in the doors market, Masonite Corporation (“Masonite”), in the Eastern District of Virginia. We subsequently received additional complaints from and on behalf of direct and indirect purchasers of interior molded doors. The suits have been consolidated into two separate actions, a Direct Purchaser Action and an Indirect Purchaser Action. The suits allege that Masonite and we violated Section 1 of the Sherman Act, and in the Indirect Purchaser Action, related state law antitrust and consumer protection laws, by engaging in a scheme to artificially raise, fix, maintain or stabilize the prices of interior molded doors in the United States. The complaints seek unquantified ordinary and treble damages, declaratory relief, interest, costs and attorneys’ fees. The Company believes the claims lack merit and intends to vigorously defend against the actions. On September 18, 2019, the court denied the defendants’ motions to dismiss the lawsuits in their entirety and granted the defendants’ motions to dismiss various state law claims and to limit all claims to a four-year statute of limitations. As a result, the plaintiffs’ damages period is limited to the four-year period between 2014 and 2018. Trial in the two matters has been set for January 2021.
We have evaluated the claims against us and recorded provisions based on management’s judgment about the probable outcome of the litigation and have included our estimates in accrued expenses in the accompanying balance sheets. See Note 9 - Accrued Expenses and Other Current Liabilities. While we expect a favorable resolution to these matters, the dispute resolution process could be lengthy, and if the plaintiffs were to prevail completely or substantially in the respective matters described above, such an outcome could have a material adverse effect on our operating results, consolidated financial position, or cash flows.
Self-Insured Risk – We self-insure substantially all of our domestic business liability risks including general liability, product liability, warranty, personal injury, auto liability, workers’ compensation and employee medical benefits. Excess insurance policies from independent insurance companies generally cover exposures between $3.0 million and $250.0 million for domestic product liability risk and exposures between $0.5 million and $250.0 million for auto, general liability, personal injury and workers’ compensation. We have no stop loss insurance covering our self-insured employee medical plan and are responsible for all claims thereunder. We estimate our provision for self-insured losses based upon an evaluation of current claim exposure and historical loss experience. Actual self-insurance losses may vary significantly from these estimates. At March 28, 2020 and December 31, 2019, our accrued liability for self-insured risks was $74.9 million and $76.6 million, respectively.
Indemnifications – At March 28, 2020, we had commitments related to certain representations made in contracts for the purchase or sale of businesses or property. These representations primarily relate to past actions such as responsibility for

25

transfer taxes if they should be claimed, and the adequacy of recorded liabilities, warranty matters, employment benefit plans, income tax matters or environmental exposures. These guarantees or indemnification responsibilities typically expire within one to three years. We are not aware of any material amounts claimed or expected to be claimed under these indemnities. From time to time and in limited geographic areas, we have entered into agreements for the sale of our products to certain customers that provide additional indemnifications for liabilities arising from construction or product defects. We cannot estimate the potential magnitude of such exposures, but to the extent specific liabilities have been identified related to product sales, liabilities have been provided in the warranty accrual in the accompanying consolidated balance sheets.
Performance Bonds and Letters of Credit – At times, we are required to provide letters of credit, surety bonds or guarantees to customers, vendors and others. Stand-by letters of credit are provided to certain customers and counterparties in the ordinary course of business as credit support for contractual performance guarantees, advanced payments received from customers, and future funding commitments. During 2019, we filed bonds in the amount of $47.7 million related to the Steves’ and Sons legal proceeding. The outstanding performance bonds and stand-by letters of credit were as follows:
(amounts in thousands)
March 28,
2020
 
December 31,
2019
Self-insurance workers’ compensation
$
23,638

 
$
23,638

Legal
48,561

 
48,561

Liability and other insurance
16,678

 
16,678

Environmental
8,286

 
8,186

Other
6,504

 
5,864

Total outstanding performance bonds and stand-by letters of credit
$
103,667

 
$
102,927


Environmental Contingencies – We periodically incur environmental liabilities associated with remediating our current and former manufacturing sites as well as penalties for not complying with environmental rules and regulations. We record a liability for remediation costs when it is probable that we will be responsible for such costs and the costs can be reasonably estimated. These environmental liabilities are estimated based on current available facts and current laws and regulations. Accordingly, it is likely that adjustments to the estimated liabilities will be necessary as additional information becomes available. Short-term environmental liabilities and settlements are recorded in accrued expenses in the accompanying consolidated balance sheets and totaled $0.7 million at both March 28, 2020 and December 31, 2019. Long-term environmental liabilities are recorded in deferred credits and other liabilities in the accompanying consolidated balance sheets. No long-term environmental liabilities were recorded at either March 28, 2020 or December 31, 2019.
Everett, Washington WADOE Action – In 2008, we entered into an Agreed Order with the WADOE to assess historic environmental contamination and remediation feasibility at our former manufacturing site in Everett, Washington. As part of this agreement, we also agreed to develop a Corrective Action Plan (“CAP”), arising from the feasibility assessment. We are currently working with WADOE to finalize our Remedial Investigation and Feasibility Study (“RI/FS”), and, on April 30, 2020, we provided the WADOE with our revised draft RI/FS. The WADOE will review our RI/FS and provide a public comment period, potentially in the second quarter of 2020, before we can develop the CAP. However, at this time, we cannot reasonably estimate the cost associated with any remedial actions we will be required to undertake under the CAP; therefore, we have not provided accruals for any remedial action in our accompanying consolidated financial statements.
Towanda, Pennsylvania Consent Order – In 2015, we entered into a COA with the PaDEP to remove a pile of wood fiber waste from our site in Towanda, Pennsylvania, which we acquired in connection with our acquisition of CMI in 2013, by using it as fuel for a boiler at that site. The COA replaced a 1995 Consent Decree between CMI’s predecessor Masonite, Inc. and PaDEP. Under the COA, we are required to achieve certain periodic removal objectives and ultimately remove the entire pile by August 31, 2022. There are currently $2.3 million in bonds posted in connection with these obligations. If we are unable to remove this pile by August 31, 2022, then the bonds will be forfeited, and we may be subject to penalties by PaDEP. We currently anticipate meeting all applicable removal deadlines; however, if our operations at this site decrease and we burn less fuel than currently anticipated, we may not be able to meet such deadlines.


26

Note 22. Employee Retirement and Pension Benefits

U.S. Defined Benefit Pension Plan – Certain U.S. hourly employees participate in our defined benefit pension plan. The plan is not open to new employees. Pension expense, as recorded in the accompanying unaudited consolidated statements of operations, is determined by using spot rate assumptions made on January 1 of each year as summarized below:
 
Three Months Ended
(amounts in thousands)
March 28,
2020
 
March 30,
2019
Components of pension benefit expense - U.S. benefit plan:
 
 
 
Administrative cost
$
1,250

 
$
1,250

Interest cost
3,725

 
3,725

Expected return on plan assets
(4,650
)
 
(4,650
)
Amortization of net actuarial pension loss
2,225

 
2,225

Pension benefit expense
$
2,550

 
$
2,550



During the three months ended March 28, 2020, we made required contributions to our U.S. defined benefit pension plan or (“the Plan”) of $1.6 million. During the three months ended March 30, 2019, we made required contributions to the Plan of $1.4 million. We did not make any voluntary contributions during any of the periods described above. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act ( the“Act”) was enacted. In conjunction with the CARES Act, companies were provided relief for defined benefit pension plans, which allows for the deferral of the remaining $6.5 million of minimum contributions for 2020.


27

Note 23. Supplemental Cash Flow Information
 
Three Months Ended
(amounts in thousands)
March 28, 2020
 
March 30, 2019
Cash Operating Activities:
 
 
 
Operating leases
$
14,337

 
$
13,453

Finance leases
47

 
12

Cash paid for amounts included in the measurement of lease liabilities
$
14,384

 
$
13,465

 
 
 
 
Non-cash Investing Activities:
 
 
 
Property, equipment and intangibles purchased in accounts payable
$
3,012

 
$
8,130

Property, equipment and intangibles purchased for debt
4,010

 
9,683

Customer accounts receivable converted to notes receivable
—

 
66

 
 
 
 
Cash Financing Activities:
 
 
 
Borrowings on long-term debt
100,075

 
115,027

Payments of long-term debt
(5,080
)
 
(7,706
)
Change in long-term debt
$
94,995

 
$
107,321

 
 
 
 
Cash paid for amounts included in the measurement of finance lease liabilities
$
328

 
$
52

 
 
 
 
Non-cash Financing Activities:
 
 
 
Prepaid insurance funded through short-term debt borrowings
$
—

 
$
1,189

Prepaid ERP costs funded through short-term debt borrowings
—

 
1,430

Shares surrendered for tax obligations for employee share-based transactions in accrued liabilities
—

 
30

Accounts payable converted to installment notes
914

 
286

 
 
 
 
Other Supplemental Cash Flow Information:
 
 
 
Cash taxes paid, net of refunds
$
5,767

 
$
5,881

Cash interest paid
1,837

 
7,902

Leased assets obtained in exchange for new finance lease liabilities
544

 
16

Leased assets obtained in exchange for new operating lease liabilities
6,339

 
4,886


Note 24. Related Party Transactions
Sale of subsidiary – In May 2019, we sold Creative Media Development, Inc. “CMD”, a subsidiary, which was part of our North America segment, for $6.5 million, resulting in a gain of $2.8 million in the second quarter of 2019. A minority shareholder of the buying group also serves on our Board of Directors. Under the Stock Purchase Agreement for CMD, we agreed to use CMD for certain advertising services totaling $7.0 million between 2019 and 2023. As of March 28, 2020, the remaining balance is $3.5 million. At March 28, 2020, there is no amount due from the related party. This sale did not have a material impact on our results of operations.
Acquired lease – As part our acquisition of VPI, we assumed operating leases on two buildings. The leases are with a former shareholder of VPI and current employee, are at market rates and resulted in an operating lease asset of $3.6 million as of the opening balance sheet. One of the leases was modified in August 2019, which increased the value by $0.6 million. The operating lease asset is $3.8 million at March 28, 2020.
Note 25. Revision of Prior Period Financial Statements
During the quarter ended June 29, 2019, we identified errors relating to accounting for fulfillment costs associated with our installation contracts at one of our European business units. This resulted in errors in accounts receivable, net, other current assets, and accrued expenses and other current liabilities. The effect of these errors was to overstate accounts receivable, net,

28

other current assets and understate accrued expenses and other current liabilities, cost of sales and SG&A expense for the years ended December 31, 2016, 2017 and 2018, including the related quarterly periods contained therein, and the three-months ended March 30, 2019.
Using the guidance in ASC Topic 250, Accounting Changes and Error Corrections, ASC Topic 250-S99-1, Assessing Materiality, and ASC Topic 250-S99-2, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, we evaluated whether our previously issued consolidated financial statements were materially misstated due to these errors and other accumulated misstatements. Based upon our evaluation of both quantitative and qualitative factors, we believe that the effects of these errors and other accumulated misstatements were not material individually or in the aggregate to any previously reported quarterly or annual period.
We have revised the prior period financial statements included in this filing to reflect the correction of these errors and other accumulated misstatements.
 
Three Months Ended
 
March 30, 2019
(amounts in thousands, except per share data)
As Reported
 
Correction
 
As Revised
Consolidated Statement of Operations:
 
 
 
 
 
Net revenues
$
1,010,906

 
$
(646
)
 
$
1,010,260

Cost of sales
$
802,458

 
$
(327
)
 
$
802,131

Gross margin
$
208,448

 
$
(319
)
 
$
208,129

Selling, general and administrative
$
163,378

 
$
722

 
$
164,100

Operating income (loss)
$
41,351

 
$
(1,041
)
 
$
40,310

Other (income) expense(1)
$
(3,195
)
 
$
(261
)
 
$
(3,456
)
Income before taxes and equity earnings
$
26,890

 
$
(780
)
 
$
26,110

Income tax expense (benefit)
$
10,337

 
$
12

 
$
10,349

Income from continuing operations, net of tax
$
16,553

 
$
(792
)
 
$
15,761

Net income (loss)
$
16,553

 
$
(792
)
 
$
15,761

Net income (loss) attributable to common shareholders
$
16,569

 
$
(792
)
 
$
15,777


(1)
Non-controlling interest of $16 for the three months ended March 30, 2019 has been reclassified to Other (income) expense to conform to the current year’s presentation.
Consolidated Statement of Cash Flow
The errors did not impact the subtotals for cash flows from operating activities, investing activities, or financing activities.
Reconciliation of pre-tax net income (loss) to Note 13 - Segment Information, Adjusted EBITDA
 
Three months ended
 
March 30, 2019
(amounts in thousands)
As Reported
 
Correction
 
As Revised
Net income (loss)
$
16,553

 
$
(792
)
 
$
15,761

Income tax expense
$
10,337

 
$
12

 
$
10,349

Non-cash foreign exchange transaction/translation (income) loss
$
(3,425
)
 
$
(261
)
 
$
(3,686
)
Other items
$
11,683

 
$
(280
)
 
$
11,403

Adjusted EBITDA
$
90,599

 
$
(1,321
)
 
$
89,278



29

Segment Information: Adjusted EBITDA
 
Three months ended
 
March 30, 2019
(amounts in thousands)
North
America
 
Europe
 
Australasia
 
Total Operating
Segments
 
Corporate
and
Unallocated
Costs
 
Total
Consolidated
As Reported
$
53,540

 
$
28,169

 
$
16,426

 
$
98,135

 
$
(7,536
)
 
$
90,599

Correction
(744
)
 
(531
)
 
(46
)
 
(1,321
)
 
—

 
(1,321
)
As Revised
$
52,796

 
$
27,638

 
$
16,380

 
$
96,814

 
$
(7,536
)
 
$
89,278



Note 26. Subsequent Events

On May 1, 2020, we amended the Australia Senior Secured Credit Facility to relax certain financial covenants and provide for an AUD 30.0 million floating rate revolving loan facility to be used for loans bearing interest at BBSY plus a margin of 1.10%, and a line fee of 0.90%, and matures on June 30, 2021. The facility may be used only when the AUD 35.0 million interchangeable facility is fully utilized. In addition, the AUD 35.0 million interchangeable facility was renewed with relaxed financial maintenance covenants to at least June 30, 2021 and its line fee increased to 0.70%, compared to a line fee of 0.50% under the previous amendment.

On May 4, 2020, we closed on our issuance of $250.0 million of senior secured notes bearing interest at 6.25% and maturing in May 2025 in a private placement exempt from registration under the Securities Act. The proceeds were net of fees and expenses associated with debt issuance and an underwriters’ discount of 1.25%, or approximately $3.1 million. Interest is payable semiannually, in arrears, each May and November through maturity, beginning November 2020.






30


Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING STATEMENTS
In addition to historical information, this 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, which are subject to the “safe harbor” created by those sections. All statements, other than statements of historical facts, included in this 10-Q are forward-looking statements. You can generally identify forward-looking statements by our use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “seek,” or “should,” or the negative thereof or other variations thereon or comparable terminology. In particular, statements about the markets in which we operate, including growth of our various markets, and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions, including the impact of COVID-19, or future events or performance contained under the heading Item 2- Management’s Discussion and Analysis of Financial Condition and Results of Operations are forward-looking statements.
We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed under the headings Item 1A- Risk Factors in our annual report on Form 10-K and Item 1A- Risk Factors and Item 2- Management’s Discussion and Analysis of Financial Condition and Results of Operations in this 10-Q may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include:

•
negative trends in overall business, financial market and economic conditions, and/or activity levels in our end markets;
•our highly competitive business environment;
•failure to timely identify or effectively respond to consumer needs, expectations or trends;
•failure to maintain the performance, reliability, quality, and service standards required by our customers;
•failure to implement our strategic initiatives, including JEM;
•acquisitions or investments in other businesses that may not be successful;
•adverse outcome of pending or future litigation;
•declines in our relationships with and/or consolidation of our key customers;
•
increases in interest rates and reduced availability of financing for the purchase of new homes and home construction and improvements;
•fluctuations in the prices of raw materials used to manufacture our products;
•delays or interruptions in the delivery of raw materials or finished goods;
•seasonal business and varying revenue and profit;
•changes in weather patterns;
•
political, economic, including pandemics, such as COVID-19, and other risks, that arise from operating a multinational business;
•exchange rate fluctuations;
•disruptions in our operations;
•manufacturing realignments and cost savings programs resulting in a decrease in short-term earnings;
•our new Enterprise Resource Planning system that we are currently implementing proving ineffective;
•security breaches and other cybersecurity incidents;
•increases in labor costs, potential labor disputes, and work stoppages at our facilities;  
•
changes in building codes that could increase the cost of our products or lower the demand for our windows and doors;

31


•compliance costs and liabilities under environmental, health, and safety laws and regulations;
•compliance costs with respect to legislative and regulatory proposals to restrict emission of GHGs;
•
lack of transparency, threat of fraud, public sector corruption, and other forms of criminal activity involving government officials;
•product liability claims, product recalls, or warranty claims;
•inability to protect our intellectual property;
•loss of key officers or employees;
•pension plan obligations;
•our current level of indebtedness;
•risks associated with any material weaknesses in our internal controls;
•the extent of Onex’s control of us; and
•
other risks and uncertainties, including those listed under Item 1A- Risk Factors in our 10-K and Item 1A- Risk Factors in this 10-Q.

Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements contained in this 10-Q are not guarantees of future performance and our actual results of operations, financial condition, and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained herein. In addition, even if our results of operations, financial condition, and liquidity, and events in the industry in which we operate, are consistent with the forward-looking statements contained in this 10-Q, they may not be predictive of results or developments in future periods.

Any forward-looking statement in this 10-Q speaks only as of the date of this 10-Q or as of the date such statement was made. We do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Unless the context requires otherwise, references in this 10-Q to “we,” “us,” “our,” “the Company,” or “JELD-WEN” mean JELD-WEN Holding, Inc., together with our consolidated subsidiaries where the context requires, including our wholly owned subsidiary JWI.

This discussion should be read in conjunction with our historical financial statements and related notes thereto and the other disclosures contained elsewhere in this 10-Q. The results of operations for the periods reflected herein are not necessarily indicative of results that may be expected for future periods, and our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including but not limited to those listed under Item 1A- Risk Factors in our annual report on Form 10-K and Item 1A - Risk Factors in this 10-Q and included elsewhere in this 10-Q.
This MD&A is a supplement to our financial statements and notes thereto included elsewhere in this 10-Q and is provided to enhance your understanding of our results of operations and financial condition. Our discussion of results of operations is presented in millions throughout the MD&A and due to rounding may not sum or calculate precisely to the totals and percentages provided in the tables. Our MD&A is organized as follows:
•
Overview and Background. This section provides a general description of our Company and reportable segments, business and industry trends, our key business strategies and background information on other matters discussed in this MD&A.
•
Consolidated Results of Operations and Operating Results by Business Segment. This section provides our analysis and outlook for the significant line items on our consolidated statements of operations, as well as other information that we deem meaningful to an understanding of our results of operations on both a consolidated basis and a business segment basis.
•
Liquidity and Capital Resources. This section contains an overview of our financing arrangements and provides an analysis of trends and uncertainties affecting liquidity, cash requirements for our business and sources and uses of our cash.
•
Critical Accounting Policies and Estimates. This section discusses the accounting policies that we consider important to the evaluation and reporting of our financial condition and results of operations, and whose application requires significant judgments or a complex estimation process.

32


Overview and Background
We are one of the world’s largest door and window manufacturers, and we hold a leading position by net revenues in the majority of the countries and markets we serve. We design, produce and distribute an extensive range of interior and exterior doors, wood, vinyl and aluminum windows, and related products for use in the new construction, R&R of residential homes and, to a lesser extent, non-residential buildings.
We operate manufacturing and distribution facilities in approximately 20 countries, located primarily in North America, Europe, and Australia. For many product lines, our manufacturing processes are vertically integrated, enhancing our range of capabilities, our ability to innovate, and our quality control as well as providing supply chain, transportation, and working capital savings.
Business Segments
Our business is organized in geographic regions to ensure integration across operations serving common end markets and customers. We have three reportable segments: North America, Europe, and Australasia. Financial information related to our business segments can be found in Note 13 - Segment Information of our financial statements included elsewhere in this 10-Q.
Acquisitions
In March 2019, we acquired VPI Quality Windows, Inc., a leading manufacturer of vinyl windows, specializing in customized solutions for mid-rise multi-family, industrial, hospitality and commercial projects, primarily in the western U.S. VPI is located in Spokane, Washington. VPI is part of our North America segment. We paid approximately $57.8 million in cash, net of cash acquired, for the acquisition of VPI.
For additional information on our acquisition activity, see Note 2 - Acquisitions to our consolidated financial statements.
Significant Developments
In March 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic. In the following weeks, global restrictions, including stay at home and similar orders, were implemented in a significant number of regions in which we operate. During the first quarter of 2020, the impact to our financial results was limited as we did not experience significant declines in our sales or customer demand, and the majority of our manufacturing facilities resumed operations due to their essential nature to the construction industry. We modified our manufacturing facilities and procedures, based on recommended public health guidelines, to ensure the health and well-being of our employees.
We took measures during the first quarter of 2020, including drawing $100.0 million on our ABL Facility, and have taken additional measures in the second quarter, including a successful $250.0 million senior secured notes offering, to enhance our liquidity and mitigate potential negative impacts to our financial results. We have also taken measures to reduce discretionary spending. We have, for example, restricted travel, implemented hiring freezes for non-essential positions, delayed merit increases and suspended all non-critical spending, such as marketing and discretionary projects. In addition, we have implemented actions to reduce salary costs globally, including our executive leadership team and Board of Directors electing to reduce their second quarter compensation by 25%, and implemented short-term employee furloughs throughout our company. Further, to maintain sufficient levels of cash and liquidity, we have suspended any non-critical capital expenditures, are deferring tax payments where permitted through COVID-19 related government subsidy programs, and are actively monitoring our accounts receivable for customers with elevated credit risk. We are monitoring the situation closely and if necessary, will implement other measures as appropriate.
The scope and nature of impacts from COVID-19, most of which are beyond the Company’s control, continue to evolve, and the outcome is uncertain. The ultimate extent of the effects of the COVID-19 pandemic on the Company, and the end markets we service, is highly uncertain and will depend on future developments and such effects could exist for an extended period even after the pandemic ends.
Results of Operations
The tables in this section summarize key components of our results of operations for the periods indicated, both in U.S. dollars and as a percentage of our net revenues. Certain percentages presented in this section have been rounded to the nearest whole number. Accordingly, totals may not equal the sum of the line items in the tables below. The results have been revised to reflect the correction of certain errors and other accumulated misstatements as described in Note 25 - Revision of Prior Period Financial Statements.

33


Comparison of the Three Months Ended March 28, 2020 to the Three Months Ended March 30, 2019
 
Three Months Ended
 
March 28, 2020
 
March 30, 2019
(amounts in thousands)
 
 
% of Net 
Revenues
 
 
% of Net 
Revenues
Net revenues
$
979,187

 
100.0
 %
 
$
1,010,260

 
100.0
 %
Cost of sales
784,818

 
80.1
 %
 
802,131

 
79.4
 %
Gross margin
194,369

 
19.9
 %
 
208,129

 
20.6
 %
Selling, general and administrative
172,584

 
17.6
 %
 
164,100

 
16.2
 %
Impairment and restructuring charges
6,545

 
0.7
 %
 
3,719

 
0.4
 %
Operating income
15,240

 
1.6
 %
 
40,310

 
4.0
 %
Interest expense, net
16,604

 
1.7
 %
 
17,656

 
1.7
 %
Other income
(2,331
)
 
(0.2
)%
 
(3,472
)
 
(0.3
)%
Income before taxes
967

 
0.1
 %
 
26,126

 
2.6
 %
Income tax expense
1,197

 
0.1
 %
 
10,349

 
1.0
 %
Net income (loss)
$
(230
)
 
—
 %
 
$
15,777

 
1.6
 %
Consolidated Results
Net Revenues – Net revenues decreased $31.1 million, or 3.1%, to $979.2 million in the three months ended March 28, 2020 from $1,010.3 million in the three months ended March 30, 2019. The decrease was driven by a decline in core revenue of 3% and adverse foreign exchange impact of 2%, partially offset by a 2% contribution from the VPI acquisition. The decrease in core revenue consisted of a 5% decline in volume/mix, partially offset by a 2% pricing benefit.
Gross Margin – Gross margin decreased $13.8 million, or 6.6%, to $194.4 million in the three months ended March 28, 2020 from $208.1 million in the three months ended March 30, 2019. Gross margin as a percentage of net revenues was 19.9% in the three months ended March 28, 2020 and 20.6% in the three months ended March 30, 2019. The decrease in gross margin and gross margin percentage was due to increased costs related to manufacturing inefficiencies in North America and unfavorable volume/mix within all regions, partially offset by favorable pricing in North America and Europe.
SG&A Expense – SG&A expense increased $8.5 million, or 5.2%, to $172.6 million in the three months ended March 28, 2020 from $164.1 million in the three months ended March 30, 2019. The increase in SG&A expense was primarily due to an increase in legal expenses from ongoing litigation and increased labor and benefit costs.
Impairment and Restructuring Charges – Impairment and restructuring charges increased $2.8 million, or 76.0%, to $6.5 million in the three months ended March 28, 2020 from $3.7 million in the three months ended March 30, 2019. Charges incurred in 2020 primarily related to severance charges for ongoing restructuring projects within our North America and Europe segments as well as impairment charges primarily related to capitalized costs of certain ERP modules due to delays in implementation and uncertainty of their future use. Charges incurred in 2019 primarily related to impairment charges for ROU assets and property and equipment held by operations impacted by restructuring as well as severance costs in our Europe and Australasia segments. For more information, refer to Note 17 - Impairment and Restructuring Charges to our unaudited consolidated financial statements included in this 10-Q.
Interest Expense, Net – Interest expense, net, decreased $1.1 million, or 6.0%, to $16.6 million in the three months ended March 28, 2020 from $17.7 million in the three months ended March 30, 2019. The decrease was primarily due to lower interest rates during 2020.
Other Income – Other income decreased $1.1 million, or 32.9%, to $2.3 million in the three months ended March 28, 2020 from $3.5 million in the three months ended March 30, 2019. The other income in the three months ended March 28, 2020 was primarily due to foreign currency gains of $2.3 million and a gain on sale of property and equipment of $2.1 million, partially offset by pension expense of $2.8 million. Other income in the three months ended March 30, 2019 was primarily due to foreign currency gains of $5.3 million and legal settlement income of $1.2 million, partially offset by pension expense of $2.7 million.
Income Taxes – Income tax expense decreased $9.2 million, or 88.4%, to $1.2 million, in the three months ended March 28, 2020 from $10.3 million in the three months ended March 30, 2019. The effective tax rate in the three months ended March 28, 2020 was 123.8% compared to 39.6% in the three months ended March 30, 2019. The 2020 tax expense of $1.2 million was primarily due

34


to the interest accrued on uncertain tax positions of $0.8 million as well as the decline and mix of income between jurisdictions in which we do business. Our 2020 annual effective tax rate was also increased due to certain projected changes in valuation allowances recorded against certain tax attribute carryforwards due to anticipated operational impacts of the COVID-19 pandemic. The 2019 tax expense of $10.3 million was primarily due to mix of income/loss between taxing jurisdictions. The net decrease in tax expense from the comparable prior year is primarily driven by expected decreases in pretax income as a result of the COVID-19 pandemic and a decrease in the shortfall for share-based compensation exercises and forfeitures.
Segment Results
We report our segment information in the same way management internally organizes the business in assessing performance and making decisions regarding allocation of resources in accordance with ASC 280-10- Segment Reporting. We have determined that we have three reportable segments, organized and managed principally by geographic region. Our reportable segments are North America, Europe and Australasia. We report all other business activities in Corporate and unallocated costs. We define Adjusted EBITDA as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity earnings of non-consolidated entities; income tax (benefit) expense; depreciation and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation expense; non-cash foreign exchange transaction/translation (income) loss; other non-cash items; other items; and costs related to debt restructuring and debt refinancing. For additional information on segment Adjusted EBITDA, see Note 13 - Segment Information to our consolidated financial statements included in this 10-Q.
Comparison of the Three Months Ended March 28, 2020 to the Three Months Ended March 30, 2019
 
 
Three Months Ended
 
 
(amounts in thousands)
 
March 28, 2020
 
March 30, 2019
 
 
Net revenues from external customers
 
 
 
 
 
% Variance
North America
 
$
586,736

 
$
565,105

 
3.8
 %
Europe
 
281,493

 
299,966

 
(6.2)
 %
Australasia
 
110,958

 
145,189

 
(23.6)
 %
Total Consolidated
 
$
979,187

 
$
1,010,260

 
(3.1)
 %
Percentage of total consolidated net revenues
 
 
 
 
 
 
North America
 
59.9
%
 
55.9
%
 
 
Europe
 
28.8
%
 
29.7
%
 
 
Australasia
 
11.3
%
 
14.4
%
 
 
Total Consolidated
 
100.0
%
 
100.0
%
 
 
Adjusted EBITDA(1)
 
 
 
 
 
 
North America
 
$
48,990

 
$
52,796

 
(7.2)
 %
Europe
 
23,326

 
27,638

 
(15.6)
 %
Australasia
 
8,725

 
16,380

 
(46.7)
 %
Corporate and unallocated costs
 
(6,533
)
 
(7,536
)
 
(13.3)
 %
Total Consolidated
 
$
74,508

 
$
89,278

 
(16.5)
 %
Adjusted EBITDA as a percentage of segment net revenues
 
 
 
 
 
 
North America
 
8.3
%
 
9.3
%
 
 
Europe
 
8.3
%
 
9.2
%
 
 
Australasia
 
7.9
%
 
11.3
%
 
 
Total Consolidated
 
7.6
%
 
8.8
%
 
 

(1)
Adjusted EBITDA is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted EBITDA, see Note 13 - Segment Information in our consolidated financial statements.
North America
Net revenues in North America increased $21.6 million, or 3.8%, to $586.7 million in the three months ended March 28, 2020 from $565.1 million in the three months ended March 30, 2019. The increase was primarily due to a 3% increase attributable to the acquisition of VPI and a 1% increase in core revenues. Core revenue improvement included a 3% pricing benefit, partially offset by a 2% decrease in volume/mix.

35


Adjusted EBITDA in North America decreased $3.8 million, or 7.2%, to $49.0 million in the three months ended March 28, 2020 from $52.8 million in the three months ended March 30, 2019. The decrease was due to unfavorable revenue mix and increased costs related to operating inefficiencies, partially offset by favorable pricing and contribution from our VPI acquisition.
Europe
Net revenues in Europe decreased $18.5 million, or 6.2%, to $281.5 million in the three months ended March 28, 2020 from $300.0 million in the three months ended March 30, 2019. The decrease was primarily due to an adverse foreign exchange impact of 3% and a decrease in core revenue of 3%, which included a 4% decrease in volume/mix, offset by a 1% pricing benefit.
Adjusted EBITDA in Europe decreased $4.3 million, or 15.6%, to $23.3 million in the three months ended March 28, 2020 from $27.6 million in the three months ended March 30, 2019. The decrease was primarily due to the impact of unfavorable foreign exchange and revenue mix, partially offset by improved productivity and favorable pricing.
Australasia
Net revenues in Australasia decreased $34.2 million, or 23.6%, to $111.0 million in the three months ended March 28, 2020 from $145.2 million in the three months ended March 30, 2019. The decrease was due to a reduction in core revenues of 18%, consisting of a decrease in volume/mix of 16% and reduced pricing of 2%, as well as adverse foreign exchange impacts of 6%.
Adjusted EBITDA in Australasia decreased $7.7 million, or 46.7%, to $8.7 million in the three months ended March 28, 2020 from $16.4 million in the three months ended March 30, 2019. The decrease was primarily due to lower volumes from market headwinds, unfavorable revenue mix, and adverse foreign exchange impacts, partially offset by improved productivity and reduced SG&A.
Liquidity and Capital Resources
Overview
We have historically funded our operations through a combination of cash from operations, draws on our revolving credit facilities, factoring agreements, and the issuance of non-revolving debt such as our Term Loan Facility and Senior Notes. Working capital, which we define as accounts receivable plus inventory less accounts payable, fluctuates throughout the year and is affected by the seasonality of sales of our products, customer payment patterns, and the translation of the balance sheets of our foreign operations into the U.S. dollar. Typically, working capital increases at the end of the first quarter and beginning of the second quarter in conjunction with, and in preparation for, the peak season for home construction and remodeling in our North America and Europe segments, which represent the substantial majority of our revenues, and decreases starting in the fourth quarter as inventory levels and accounts receivable decline. Inventories fluctuate for raw materials with long delivery lead times, such as steel, as we work through prior shipments and take delivery of new orders.
As of March 28, 2020, our cash balances, including $0.3 million of restricted cash, consisted of $103.2 million in the U.S. and $111.4 million in non-U.S. subsidiaries. In March 2020, we drew $100.0 million under our ABL Facility as a precautionary measure to ensure funding for our seasonal working capital cash requirements given the recent significant impact on the global financial market and economy as a result of the COVID-19 pandemic. Although there is uncertainty surrounding the anticipated impact of the recent COVID-19 pandemic on our operating results and liquidity, based on our current level of operations, the seasonality of our business and anticipated growth, we believe that cash provided by operations and other sources of liquidity, including cash, cash equivalents and borrowings under our revolving credit facilities, will provide adequate liquidity for ongoing operations, planned capital expenditures and other investments, and debt service requirements for at least the next twelve months.
In May 2020, we issued $250.0 million in senior secured notes, the proceeds of which were used to repay the outstanding balance under our ABL Facility and the remainder to be used for general corporate purposes. In addition, we amended our Australia Senior Credit Facility to add AUD 30.0 million of additional revolving loan capacity. Refer to Note 26 - Subsequent Events for additional details.
As of March 28, 2020, we had total liquidity (a non-GAAP measure) of $431.2 million, consisting of $214.3 million in unrestricted cash, $204.0 million available for borrowing under the ABL Facility, and AUD 21.3 million ($12.9 million USD) available for borrowing under the Australia Senior Secured Credit Facility compared to total liquidity of $554.5 million as of December 31, 2019. The decrease in total liquidity was primarily due to increases in capital expenditures and changes in working capital.
We may, from time to time, refinance, reprice, extend, retire or otherwise modify our outstanding debt to lower our interest payments, reduce our debt or otherwise improve our financial position. These actions may include repricing amendments, extensions, and/or opportunistic refinancing of debt. The amount of debt that may be refinanced, repriced, extended, retired or otherwise modified, if any, will depend on market conditions, trading levels of our debt, our cash position, compliance with debt covenants and other considerations. Our affiliates may also purchase our debt from time to time, through open market purchases or other transactions. In

36


such cases, our debt may not be retired, in which case we would continue to pay interest in accordance with the terms of the debt, and we would continue to reflect the debt as outstanding in our consolidated balance sheets.
Based on hypothetical variable rate debt that would have resulted from drawing each revolving credit facility up to the full commitment amount, a 1.0% decrease in interest rates would have reduced our interest expense by $2.6 million for the three months ended March 28, 2020. A 1.0% increase in interest rates would have increased our interest expense by $2.6 million for the same period. The impact of these hypothetical changes would have been partially mitigated by interest rate caps and the floors that apply to certain of our debt agreements.
Borrowings and Refinancings
In May 2020, we issued $250.0 million in senior secured notes, the proceeds of which were used to repay the outstanding balance under our ABL Facility and the remainder to be used for general corporate purposes. In addition, we amended our Australia Senior Credit Facility to add AUD 30.0 million of additional revolving loan capacity. Refer to Note 26 - Subsequent Events for additional details.
In March 2020, we borrowed $100.0 million on our ABL Facility, which was repaid in full in May 2020. In December 2019, we amended our ABL facility to reflect current banking regulatory requirements, which do not have a financial impact.
In September 2019, we amended the Term Loan Facility to provide for an incremental aggregate principal amount of $125.0 million and used the proceeds to repay $115.0 million of outstanding borrowings under the ABL Facility.
In June 2019, we reallocated AUD 5.0 million from the term loan commitment to the interchangeable commitment of the Australia Senior Secured Credit Facility.
As of March 28, 2020, we were in compliance with the terms of all of our Credit Facilities.
Our results have been and will continue to be impacted by substantial changes in our net interest expense throughout the periods presented and into the future. See Note 11 - Long-Term Debt in our consolidated financial statements for additional details.
Factoring arrangements
Our ABS subsidiary, acquired in March 2018, has entered into factoring agreements with a U.S.-based financial institution under which it can elect to sell certain of its accounts receivable under non-recourse agreements. These transactions are treated as a sale and are accounted for as a reduction in accounts receivable because the agreements transfer effective control over and risk of non-collection to the factor. Thus, cash proceeds from these arrangements are reflected as operating activities, including the change of accounts receivable on our statement of cash flows each period. We do not service any factored accounts after the factoring has occurred and do not have any servicing assets or liabilities. We utilize factoring arrangements as part of our financing to manage working capital. The aggregate gross amount factored under these arrangements was $17.9 million and $19.0 million for the three months ended March 28, 2020 and March 30, 2019, respectively. The cost of factoring is reflected in the accompanying consolidated statements of operations as interest expense with other financing costs and was $0.1 million and $0.2 million for the three months ended March 28, 2020 and March 30, 2019, respectively.
Cash Flows
The following table summarizes the changes to our cash flows for the periods presented:
 
 
Three Months Ended
(amounts in thousands)
 
March 28,
2020
 
March 30,
2019
Cash provided by (used in):
 
 
 
 
Operating activities
 
$
(76,575
)
 
$
(27,958
)
Investing activities
 
(22,366
)
 
(88,936
)
Financing activities
 
89,290

 
93,471

Effect of changes in exchange rates on cash and cash equivalents
 
(5,616
)
 
63

Net change in cash and cash equivalents
 
$
(15,267
)
 
$
(23,360
)

37


Cash Flow from Operations
Net cash used in operating activities increased $48.6 million to $76.6 million in the three months ended March 28, 2020 from $28.0 million in net cash used in operating activities in the three months ended March 30, 2019. The increase in cash used in operating activities was due primarily to the absence of cash flow benefits recognized in the prior year from timing and changes of vendor terms, decreased earnings, other seasonal changes due to seasonal working capital requirements, and negative impacts from foreign exchange.
Cash Flow from Investing Activities
Net cash used in investing activities decreased $66.5 million to $22.4 million in the three months ended March 28, 2020 from $88.9 million in the three months ended March 30, 2019 primarily due to a decrease in the cash used for acquisitions.
Cash Flow from Financing Activities
Net cash provided by financing activities was $89.3 million in the three months ended March 28, 2020 and consisted primarily of increased borrowings of $95.0 million, offset by repurchases of our Common Stock of $5.0 million.
Net cash provided by financing activities was $93.5 million in the three months ended March 30, 2019 and consisted primarily of increased borrowings of $107.3 million, offset by repurchases of our common stock of $15.0 million.
Critical Accounting Policies and Estimates
Management’s Discussion and Analysis of Results of Operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of financial statements in conformity with those accounting principles requires management to use judgments in making estimates and assumptions based on the relevant information available at the end of each period. These estimates and assumptions may have a significant effect on reported amounts of assets and liabilities, revenue and expenses, as well as the disclosure of contingent assets and liabilities because they result primarily from the need to make estimates and assumptions on matters that are inherently uncertain. Actual results may differ from estimates.
Except for certain policy changes due to the adoption of ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, management believes there have been no significant policy changes during the three months ended March 28, 2020. For information about recently issued accounting standards, see Note 1 - Description of Company and Summary of Significant Accounting Policies in our unaudited consolidated financial statements.
Holding Company Status
We are a holding company that conducts all of our operations through subsidiaries. The majority of our operating income is derived from JWI, our main operating subsidiary. Consequently, we rely on dividends or advances from our subsidiaries. The ability of our subsidiaries to pay dividends to us is subject to applicable local law and may be limited due to the terms of other contractual arrangements, including our Credit Facilities and the Senior Notes.
The Australia Senior Secured Credit Facility also contains restrictions on dividends that limit the amount of cash that the obligors under these facilities can distribute to JWI. Obligors under the Australia Senior Secured Credit Facility may pay dividends only to the extent they do not exceed 80% of after tax net profits (with a one-year carryforward of unused amounts) and only while no default is continuing under such agreement. For further information regarding the Australia Senior Secured Credit Facility, see Note 11 - Long-Term Debt in our consolidated financial statements.
The amount of our consolidated net assets that were available to be distributed under our credit facilities as of March 28, 2020 was $565.2 million.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.


38


Item 3 - Quantitative and Qualitative Disclosures About Market Risk

We are exposed to various types of market risks, including the effects of adverse fluctuations in foreign currency exchange rates, adverse changes in interest rates, and adverse movements in commodity prices for products we use in our manufacturing. To reduce our exposure to these risks, we maintain risk management controls and policies to monitor these risks and take appropriate actions to attempt to mitigate such forms of market risk. Our market risks have not changed significantly from those disclosed in the 10-K.
Item 4 - Controls and Procedures
Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), which are designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act, including this Report, are recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed by the Company under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive officer (“CEO”) and principal financial officer (“CFO”), as appropriate to allow timely decisions regarding required disclosure. The Company’s management, including the Company’s CEO and CFO, conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Report and, based on that evaluation, the CEO and CFO concluded that due to material weaknesses in internal control over financial reporting as described in Item 9A - Controls and Procedures in our Form 10-K, the Company’s disclosure controls and procedures were not effective as of March 28, 2020.
Remediation Plan for Previously Identified Material Weaknesses
As described in Item 9A - Controls and Procedures in our Form 10-K, we identified material weaknesses in our internal control over financial reporting and the Company’s management implemented a remediation plan to address the control deficiencies that led to the material weaknesses identified therein. The remediation plan includes the following:
•
Enhance and supplement the finance team in Europe by increasing the number of roles, reassigning responsibilities, and adding additional resources with an appropriate level of knowledge and experience in internal control over financial reporting commensurate with the financial reporting complexities of the organization;
•
Enhance the tone, communication and overall awareness of the importance of internal control over financial reporting from executive management;
•
Evaluate corporate and segment monitoring controls to ensure they are designed and operating at the appropriate level of precision required to support risk mitigation;
•
Implement enhancements to the design of our customer pricing controls in Europe;
•
Implement enhancements to the design of our journal entry controls in Europe;
•
Implement enhancements to the design of our controls related to the reconciliation of subsidiary ledger financial information used in the consolidated financial statements;
•
Strengthen procedures and set guidelines for documentation of controls throughout our domestic and international locations for consistency of application; and
•
Institute additional training programs that occur on a regular basis related to internal control over financial reporting for our world-wide finance and accounting personnel.

39


During the period ended March 28, 2020, we executed the remediation plan above by:
•
The onboarding of additional personnel, including an experienced finance executive, in Europe with knowledge and experience in internal control over financial reporting;
•
conducting quarterly web-based training sessions on internal controls over financial reporting, monitoring controls, complex accounting topics, account reconciliations and journal entry controls in Europe; and
•
implementing enhancements to closing processes that included the continuation of the centralization of certain tasks, development of manuals and standardized templates to enhance the evidence supporting the local teams’ execution of internal control over financial reporting.
Based on the actions taken to date, while management believes that it now has the requisite personnel to consistently operate the controls as designed, additional controls may need to be designed and implemented as part of the remediation plan, especially with respect to pricing. Additionally, for controls that were newly designed and implemented in 2019, management determined that a sustained period of operating effectiveness is required to conclude that the controls are operating effectively. Accordingly, the material weaknesses described have not been remediated as of March 28, 2020.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the Company’s most recently completed quarter ended March 28, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1 - Legal Proceedings
We are involved in various legal proceedings, claims, and government audits arising in the ordinary course of business. We record our best estimate of a loss when the loss is considered probable and the amount of such loss can be reasonably estimated. When a loss is probable and there is a range of estimated loss with no best estimate within the range, we record the minimum estimated liability related to the lawsuit or claim. As additional information becomes available, we reassess the potential liability and revise our accruals, if necessary. Because of uncertainties related to the resolution of lawsuits and claims, the ultimate outcome may differ materially from our estimates.
Other than the matters described below, as of March 28, 2020, there are no current proceedings or litigation matters involving the Company or its property that we believe would have a material adverse effect on our consolidated financial position or cash flows, although they could have a material adverse effect on our operating results for a particular reporting period.
Steves & Sons Litigation
We sell molded door skins to certain customers pursuant to long-term contracts, and these customers in turn use the molded door skins to manufacture interior doors and compete directly against us in the marketplace. We gave notice of termination of one of these contracts and, on June 29, 2016, the counterparty to the agreement, Steves and Sons, Inc. (“Steves”) filed a claim against JWI in the U.S. District Court for the Eastern District of Virginia, Richmond Division (“Eastern District of Virginia”). The complaint alleged that our acquisition of CMI, a competitor in the molded door skins market, together with subsequent price increases and other alleged acts and omissions, violated antitrust laws, and constituted a breach of contract and breach of warranty. Specifically, the complaint alleged that our acquisition of CMI substantially lessened competition in the molded door skins market. The complaint sought declaratory relief, ordinary and treble damages, and injunctive relief, including divestiture of certain assets acquired in the CMI acquisition.
In February 2018, a jury in the Eastern District of Virginia returned a verdict that was unfavorable to JWI with respect to Steves’ claims that our acquisition of CMI violated Section 7 of the Clayton Act and found that JWI breached the supply agreement between the parties. The verdict awarded Steves $12.2 million for past damages under both the Clayton Act and breach of contract claims and $46.5 million in future lost profits under the Clayton Act claim.
On March 13, 2019, the presiding judge entered an Amended Final Judgment Order awarding $36.5 million in past damages under the Clayton Act (representing a trebling of the jury’s verdict) and granting divestiture of CMI, subject to appeal. The judgment also conditionally awarded damages in the event the judgment is overturned on appeal. Specifically, the court awarded $139.4 million as future antitrust damages in the event the divestiture order is overturned on appeal and $9.9 million as past contract damages in the event both the divestiture and antitrust claims are overturned on appeal.

40


JELD-WEN filed a supersedeas bond and notice of appeal of the judgment, which is scheduled for hearing by the Fourth Circuit Court of Appeals in May 2020, but could be rescheduled to a later date due to the COVID-19 pandemic.
On April 12, 2019, the plaintiffs filed a petition requesting an award of their fees and a bill of costs seeking $28.4 million in attorneys’ fees and $1.7 million in costs. That petition remains pending and subject to further appeal. On November 19, 2019, the presiding judge entered an order for further relief awarding Steves an additional $7.1 million in damages for pricing differences from the date of the underlying jury verdict through May 31, 2019. We have also appealed that ruling. On April 14, 2020, Steves filed a motion for further supplemental relief for pricing differences from the date of the prior order through the present. We are in the process of reviewing that new motion and are in the process of filing a responsive pleading. No hearing date on the new motion has been set.
We continue to believe that Steves’ claims lack merit, Steves’ damages calculations are speculative and excessive, and Steves is not entitled in any event to the extraordinary remedy of divestiture of CMI. We believe that multiple pretrial and trial rulings were erroneous and improperly limited the Company’s defenses, and that the judgment in accordance with the verdict was improper for several reasons under applicable law. The judgment, if ultimately upheld after exhaustion of our appellate remedies, could have a material adverse effect on our financial position, operating results, or cash flows, particularly for the reporting period in which a loss is recorded or a payment is required. Because the operations acquired from CMI have been fully integrated into the Company’s operations, divestiture of those operations would be difficult if not impossible and, therefore, it is not possible to estimate the cost of any final divestiture order or the extent to which such an order would have a material adverse effect on our financial position, operating results or cash flows.
During the course of the proceedings in the Eastern District of Virginia, we discovered certain facts that led us to conclude that Steves, its principals and certain former employees of the Company had misappropriated Company trade secrets, violated the terms of various agreements between the Company and those parties, and violated other laws. On May 11, 2018, a jury in the Eastern District of Virginia returned a verdict on our trade secrets claims against Steves and awarded damages in the amount of $1.2 million. The presiding judge entered a judgment in our favor for those damages and the entire amount has been paid by Steves. On August 16, 2019, the presiding judge granted Steves’ request for an injunction, prohibiting us from pursuing certain claims against individual defendants pending in Bexar County, Texas. These claims have been stayed pending appeal.
Separately, on February 14, 2020, Steves filed a complaint and motion for preliminary injunction in the U.S. District Court for the Eastern District of Virginia, Richmond Division, alleging that we breached the long-term supply agreement between the parties, among other claims, including by incorrectly calculating the allocation of door skins owed to Steves. Steves is seeking an additional allotment of door skins and damages for violation of antitrust laws, tortious interference, and breach of contract. On April 10, 2020, the presiding judge granted Steves’ motion for preliminary injunction and the parties settled the issues underlying the preliminary injunction on April 30, but reserved the right to appeal the ruling in the Fourth Circuit Court of Appeals. The Company believes all the claims lack merit and has moved to dismiss the antitrust and tortious interference claims. A trial on this matter is currently expected in July 2020.
Cambridge Retirement System Litigation
On February 19, 2020, Cambridge Retirement System filed a putative class action lawsuit in the U.S. District Court for the Eastern District of Virginia against the Company, current and former Company executives and various Onex-related entities alleging violations of Section 10(b) and Rule 10b-5 of the Exchange Act, as well as violations of Section 20(a) of the Exchange Act against the individual defendants and Onex-related entities.  The lawsuit seeks compensatory damages, equitable relief and an award of attorneys’ fees and costs. The Company believes the claims lack merit and intends to vigorously defend against the action. 
In Re: Interior Molded Doors Antitrust Litigation
On October 19, 2018, Grubb Lumber Company, on behalf of itself and others similarly situated, filed a putative class action lawsuit against us and one of our competitors in the doors market, Masonite Corporation (“Masonite”), in the Eastern District of Virginia. We subsequently received additional complaints from and on behalf of direct and indirect purchasers of interior molded doors. The suits have been consolidated into two separate actions, a Direct Purchaser Action and an Indirect Purchaser Action. The suits allege that Masonite and we violated Section 1 of the Sherman Act, and in the Indirect Purchaser Action, related state law antitrust and consumer protection laws, by engaging in a scheme to artificially raise, fix, maintain or stabilize the prices of interior molded doors in the United States. The complaints seek unquantified ordinary and treble damages, declaratory relief, interest, costs and attorneys’ fees. The Company believes the claims lack merit and intends to vigorously defend against the actions. On September 18, 2019, the court denied the defendants’ motions to dismiss the lawsuits in their entirety and granted the defendants’ motions to dismiss various state law claims and to limit all claims to a four-year statute of limitations. As a result, the plaintiffs’ damages period is limited to the four-year period between 2014 and 2018. Trial in the two matters has been set for January 2021.
We have evaluated the claims against us and recorded provisions based on management’s judgment about the probable outcome of the litigation and have included our estimates in accrued expenses in the accompanying balance sheets. See Note 9 -

41


Accrued Expenses and Other Current Liabilities. While we expect a favorable resolution to these matters, the dispute resolution process could be lengthy, and if the plaintiffs were to prevail completely or substantially in the respective matters described above, such an outcome could have a material adverse effect on our operating results, consolidated financial position, or cash flows.

Item 1A - Risk Factors

Except for the updates to the risk factors set forth below, there have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K included in Part I Item 1A - Risk Factors for the year ended December 31, 2019.

The outbreak of COVID-19 has had, and may continue to have, a negative impact on the global economy and on our business, operations, and results.

The COVID-19 pandemic, and the measures taken to contain or mitigate it, have had dramatic adverse consequences for the economy, including on demand for goods and services, operations, supply chains and financial markets. The nature and scope of the consequences to date are difficult to evaluate precisely, and their future course is impossible to predict with confidence.
The COVID-19 crisis has already had several significant effects on our employees, operations, supply chain, distribution system, customer demand, the housing market and general market and economic conditions. The effects to date have included the following:
•
decreased demand for our products as a result of a slowdown in the U.S. and global economies and resulting decreases in construction and R&R;
•
increased storage costs as a result of larger volume of inventory that remains unsold; and
•
uncertain expense management in light of continued efforts to protect our employees and operational issues resulting from absenteeism and closures experienced by our facilities globally.
These effects began in the latter weeks of March 2020 and have continued to date, with the impact of COVID-19 expected to be more significant in the second quarter of 2020 as compared to the first quarter. In response to the effects of COVID-19, our named executive officers have elected to reduce their 2020 base salaries by 25% for the months of April, May and June of 2020, or until such time as ratified by the Compensation Committee of our Board. Our non-employee directors have also elected to reduce their annual cash fees and committee chair fees by 25% until such time as the Board determines.
We have also temporarily suspended production at locations that represent, in the aggregate, approximately 10% of our revenues for the year ended December 31, 2019. Initiatives, including travel restrictions and quarantines, have and may continue to impact a significant percentage of our workforce and the workforce of our suppliers or transportation providers as they are unable to work as a result of the disease outbreak. If additional factory closures are required, current closures are extended or reductions in capacity utilization levels occur, we expect to incur additional direct costs due to reduced productivity and lost revenue. If our suppliers experience closures or reductions in their capacity utilization levels in the future, we may have difficulty sourcing materials necessary to fulfill production requirements or be required to pay a higher price to fulfill our requirements.
Finally, in May 2020, we issued $250.0 million in senior secured notes, the proceeds of which were used to repay the outstanding balance under our ABL Facility and the remainder to be used for general corporate purposes. We cannot ensure you that the available proceeds, or any of our other actions, will be sufficient to avoid liquidity constraints in the future or to mitigate any material or adverse effect of COVID-19 on our business, financial condition or results of operations.
The effects of the COVID-19 crisis could be aggravated if the crisis continues, and we could also see additional impacts that might include the following:
•
complete or partial closures of, or other operational issues at, one or more of our manufacturing or distribution facilities resulting from government action;
•
difficulty sourcing materials necessary to fulfill production requirements or higher prices to fulfill our requirements as a result of suppliers experiencing closures or reductions in their capacity utilization levels;
•
reduced economic activity severely impacting our customers’ financial condition and liquidity, reducing the likelihood they will be purchasing additional products from us and increasing the likelihood they may require additional time to pay us or will fail to pay us at all, which could significantly increase the amount of accounts receivable and require us to record additional allowances for doubtful accounts;
•
reduced economic activity resulting in a prolonged recession, which could negatively impact consumer discretionary spending;
•
a decrease in the principal that may be drawn under our ABL Facility as a result of a decrease in our accounts receivable and inventory;

42


•
difficulty accessing debt and equity capital on attractive terms, or at all, an impact on our credit ratings, and a severe disruption and instability in the global financial markets or deterioration in credit and financing conditions that affect our access to capital necessary to fund business operations or to address maturing liabilities on a timely basis;
•
negative impact on our future compliance with financial covenants under our Corporate Credit Facilities and other debt agreements, which could result in a default and potentially an acceleration of indebtedness; and
•
the potential negative impact on the health of our personnel, particularly if a significant number of them are impacted, decreasing our ability to ensure business continuity during this disruption.
If these effects are sustained, they could have accounting consequences such as impairments of fixed assets or goodwill. They could affect our ability to operate effective internal control over financial reporting. They could also affect our ability to execute our expansion plans or invest in research and development.
The adverse effect on our business, financial condition or results of operations of any of the matters described above could be material. The future impact of the COVID-19 crisis on our business, financial condition or results of operations is highly uncertain and will depend on numerous evolving factors that we cannot predict, including, but not limited to:
•
the duration, scope, and severity of the COVID-19 pandemic;
•
the disruption or delay of production and delivery of materials and products in our supply chain;
•
the impact of travel bans, work-from-home policies, or shelter-in-place orders;
•
the temporary or prolonged shutdown of manufacturing facilities and decreased retail traffic;
•
staffing shortages;
•
general economic, financial, and industry conditions, particularly conditions relating to liquidity, financial performance, and related credit issues in our industry, which may be amplified by the effects of COVID-19; and
•
the long-term effects of COVID-19 on the national and global economy, including on consumer confidence and spending, financial markets and the availability of credit for us, our suppliers and our customers.
To the extent the COVID-19 pandemic or any other global health crisis does adversely affect our business, financial condition or results of operations, it may also have the effect of heightening many of the “Risk Factors” included herein, in our Annual Report on Form 10-K included in Part I Item 1A - Risk Factors for the year ended December 31, 2019, or as disclosed in any subsequent filings with the SEC.

Prices and availability of the raw materials we use to manufacture our products are subject to fluctuations, and we may be unable to pass along to our customers the effects of any price increases.

We use wood, glass, vinyl and other plastics, fiberglass and other composites, aluminum, steel and other metals, as well as hardware and other components to manufacture our products. Prices and availability of our materials fluctuate for a variety of reasons beyond our control, many of which cannot be anticipated with any degree of reliability. Our most significant raw materials include logs and lumber, vinyl extrusions, glass, steel, and aluminum, each of which has been subject to periods of rapid and significant fluctuations in price. The reasons for these fluctuations include, among other things, variable worldwide supply and demand across different industries, speculation in commodities futures, general economic or environmental conditions, labor costs, competition, import duties, tariffs, worldwide currency fluctuations, freight, regulatory costs, and product and process evolutions that impact demand for the same materials.
The U.S. has imposed tariffs on certain products imported into the U.S. from China, as well as tariffs on certain steel and aluminum products imported from certain countries, and could impose additional tariffs or trade restrictions. The imposition of tariffs may impact the prices of materials purchased outside of the U.S. and include goods in transit as well as increasing the price of domestically sourced materials, including, in particular, steel and aluminum. Impositions of tariffs by other countries could also impact pricing and availability of raw materials. As another example, as global demand for key chemicals increases, the limited number of suppliers and investment in greater supply capacity drives increased global pricing. Additionally, anti-dumping and countervailing duty trade cases, such as the January 8, 2020, Coalition of American Millwork Producers’ anti-dumping petitions on imports of wood moldings and millwork products from Brazil and China and a countervailing duty petition on imports of wood moldings and millwork products from China, could impact our business and results of operations. While we believe our exposure to the potential increased costs of these tariffs and duties is no greater than the industry as a whole, our business and results of operations may be adversely affected if our efforts to mitigate their effects are unsuccessful.
We have short-term supply contracts with certain of our largest suppliers that limit our exposure to short-term fluctuations in prices and availability of our materials, but we are susceptible to longer-term fluctuations in prices. We generally do not hedge against commodity price fluctuations. Significant increases in the prices of raw materials for finished goods, including as a result of

43


significant or protracted material shortages due to pandemic or otherwise, may be difficult to pass through to customers and may negatively impact our profitability and net revenues. We may attempt to modify products that use certain raw materials, but these changes may not be successful.

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

A summary of our repurchases of Common Stock during the first quarter of 2020 is as follows (in thousands, except share and per share amounts):
 
 
(a)
 
(b)
 
(c)
 
(d)
Period
 
Total Number of Shares (or Units) Purchased 1
 
Average Price Paid Per Share (or Unit) 2
 
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs
 
Maximum Number (or Approximate Dollar Value) of Shares (or Units) That May Yet Be Purchased Under The Plans or Programs
January 1, 2020 - January 25, 2020
 
—
 
$—
 
—
 
$175,000
January 26, 2020 - February 22, 2020
 
32,179
 
$21.76
 
32,179
 
$174,300
February 23, 2020 - March 28, 2020
 
233,410
 
$18.42
 
233,410
 
$170,000
Total
 
265,589
 
$18.83
 
265,589
 
 

1 In April 2018, the Board of Directors authorized a $250 million share repurchase program under which $105.0 million remained available as of September 28, 2019 and would expire on December 31, 2019. On November 4, 2019, the Board of Directors authorized an increase to the remaining authorization under the share repurchase program to a total of $175.0 million with no expiration.

2 Average price paid per share includes costs associated with the repurchases.
Item 5 - Other Information
None.




44


Item 6 - Exhibits

Exhibit No.
 
Exhibit Description
Form
File No.
Exhibit
 
Filing Date
4.1
 
8-K
001-38000


4.1
 
May 5, 2020
4.2
 

8-K
001-38000


4.2
 
May 5, 2020
31.1*
 
 
 
 
 
 
31.2*
 
 
 
 
 
 
32.1*
 
 
 
 
 
 
101.INS*
 
XBRL Instance Document-the instance document does not appear in this Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
 
 
 
 
 
101.SCH*
 
Inline XBRL Taxonomy Extension Schema Document.
 
 
 
 
 
101.CAL*
 
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
 
 
 
 
 
101.DEF*
 
Inline XBRL Taxonomy Extension Definition Linkbase Document.
 
 
 
 
 
101.LAB*
 
Inline XBRL Taxonomy Extension Label Linkbase Document.
 
 
 
 
 
101.PRE*
 
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
 
 
 
 
 
104*
 
Cover page Interactive Data file (formatted as Inline XBRL and contained in Exhibit 101)
 
 
 
 
 
*
Filed herewith
 
 
 
 
 


45


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
JELD-WEN HOLDING, INC.
(Registrant)
 
 
By:
/s/ John Linker
 
John Linker
 
Chief Financial Officer

Date: May 6, 2020

46

JELD WEN (NYSE:JELD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more JELD WEN Charts.
JELD WEN (NYSE:JELD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more JELD WEN Charts.